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Background of the study: 
 With impaired renal function, decreased glomerular filtration rate and 
accumulation and retention of various products of renal failure the oral cavity may 
shows a variety of changes as the body progresses through an azotemic to uremic 
state. In 90% of hemodialysis patient oral manifestation are evident which may be due 
to disease process or as a result of treatment. Studies have been conducted regarding 
colonization of yeast in hemodialysis patients. However there is a gap in the 
knowledge regarding assessment of Candida subspecies and its correlation with oral 
lesions in hemodialysis patient which aid in prophylactic treatment. Prevalence of 
Candidiasis, Uremic Stomatitis, Uremic frost and colonization of Candida Subspecies 
will open eyes in this new research.  
Aim: 
  To assess the presence of Candidiasis, Uremic Stomatitis, and Uremic 
frost in patients undergoing hemodialysis.   
 To assess the presence of various subspecies of Candida in patients 
with chronic renal disease undergoing hemodialysis 
Materials & Methods: 
A comparative cross-sectional study to determine the presence of Candidiasis, 
Uremic Stomatitis, and Uremic frost and various subspecies of Candida in patients 
undergoing hemodialysis was carried out in the outpatient department and the study 
sample consisted of 50 chronic renal failure  patients. The oral health status was 
assessed clinically for each patient and recorded. The data was analysed by Statistical 
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Package for Social Sciences (SPSS 16.0). Chi square test was applied to find the 
statistical significance between the groups. 
Results:  
The analysis demonstrated significant association between colonization by 
yeasts and patient’s age (P = 0.04), chief complaint (P = 0.004), duration of the 
diseases (P = 0.03), duration of dialysis treatment (P = 0.03) and oral hygiene status 
(P = 0.03). However, no significant association was observed with gender.  
The percentage of patients affected by the disease was found to be higher 
between the age group of 40 -60 years of age and the analysis demonstrated that the 
results in relation to the presence of oral lesion and age changed and were no longer 
significant for the presence of yeasts. Common dental problems associated with these 
patients are periodontitis and dental caries.  Despite optimal dialysis, oral disease may 
be increased in these patients treated due to their   lower uptake of public dental 
services, as well as increased malnutrition and inflammation. 
Nevertheless, chronic kidney disease patients undergoing hemodialysis 
treatment  were more likely to carry yeasts and its prevalence is higher when lesions 
were present in the oral cavity.  But our results demonstrated only 18 (36%) patients 
with CKD undergoing HT were colonized by yeasts, from which a total of 2 
subspecies were only isolated and identified, all belonging to the genus Candida with 
the predominance of C. albicans (22%). 
 Clinical assessment detected more than one type of lesion in one of the 18 
patients with CKD undergoing HT with oral lesions. Candidiasis (acute 
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pseudomembranous candidiasis, chronic atrophic candidiasis or angular cheilitis) was 
confirmed in 17 (34%) of the 18 lesions suggestive of the disease. Among the 
remaining lesion found, the diagnosis suggested uremic stomatits. Uremic frost was 
not reported in any patients.  
 The only type of lesion to show positive association with the presence of 
yeasts was chronic erythematosus candidiasis, which is the kind of lesion typically 
resulting from the use of dental prosthesis.  
Conclusion:  
It is concluded that the oral cavity  can reveal signs of undiagnosed renal 
failure, hence oral health care providers must be well aware of signs and symptoms to 
refer such patients to a physician for further investigation as well as manage and treat 
the oral health complications. 
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The kidneys have a vital role in maintaining a stable internal environment. The 
function of kidneys include regulating the acid–base and fluid–electrolyte balance by 
filtering blood, selectively reabsorbing water and electrolytes, and excreting urine. In 
addition, the kidneys also excrete metabolic waste products, including urea, 
creatinine, and uric acid. Apart from these functions, the kidneys also have a vital 
endocrine function, secreting renin, the active form of vitamin D, and erythropoietin. 
These hormones are important in maintaining blood pressure, calcium metabolism, 
and the synthesis of erythrocytes.
1 
Renal failure expresses the loss of functional capacity of the nephrons 
independently of its etiology. Disorders of the kidneys can be classified into disorders 
of hydrogen ion concentration (pH) and electrolytes, acute kidney injury (AKI), 
chronic kidney disease (CKD), and end-stage renal disease (ESRD) or uremic 
syndrome. It is classified into acute and chronic renal failure, based on its form of 
onset and on the possibilities for recovery of the structural lesion.
1
 Although acute 
renal failure is reversible in the majority of cases, chronic renal failure presents a 
progressive course towards terminal renal failure, even if the cause of the initial 
nephropathy disappears. 
 
ESRD occurs when the kidney function is impaired towards 5-10% of the 
original capacity requiring either hemodialysis (HD) or peritoneal dialysis treatment 
(PD) or renal transplantation (TX). An extra-corporal device is used in HD, whereas 
the peritoneal membrane acts as a filter in PD .
2
 TX patients receive their allograft 
from living or cadaveric donors. To prevent allograft rejection, immunosuppressant 
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therapy is required including the use of prednisolone, cyclosporine or tacrolimus, 
which could affect the oral health.
 
End stage renal disease (ESRD) encompasses a wide range of metabolic 
disorders affecting every system which leads to a very immunocompromised 
situation.   More than a million people worldwide have their lives extended through 
the development of renal replacement therapy.  In India, a conservative estimate of 
ESRD burden, based on a population of 1.1 billion is that 1,650,000-2,200,000 people 
develop ESRD annually and the number of patients with chronic kidney disease, stage 
5 (CKD), undergoing hemodialysis treatment (HT) has been increasing at a rate of 
6.3% a year.
1
 
 
CKD is defined by the National Kidney Foundation Kidney Disease Outcomes 
Quality Initiative as either of the following: (1) the presence of markers of kidney 
damage for >3 months, as defined by structural or functional abnormalities  of the 
kidney with or without a decrease in GFR manifest either by pathologic abnormalities 
or other markers of kidney damage, including abnormalities in the composition of 
blood or urine, or abnormalities in imaging tests; (2) the presence of GFR < 60 
mL/min/1.73 m2 for >3 months, with or without other signs of kidney damage.
 
Chronic renal failure creates a predisposition to opportunistic infections, 
which include mainly fungal origin. In this stage of the renal disease, patients are 
often colonized by yeasts of the genus Candida spp., and consequently, the chance of 
these microorganisms evolving to fungal infections is high. Yeast colonization is seen 
as a predisposing factor for invasive fungal infection. 
2
In the majority of cases, these 
infections are cutaneous affecting  moist mucosal membranes.
 
 However, the 
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dissemination of yeasts into the bloodstream is common, which can lead to 
candidemia. Candidemia or invasive candidiasis (IC) is a serious public health 
problem due to the high rates of morbidity and mortality.
1
 In addition hemodialysis 
has been considered among the main risk factor for candidemia.
3 
Oral candidiasis (OC) is an intermediary form between yeast colonization and 
IC. Although OC is a superficial oral infectious lesion which is clinically detectable, 
serious consideration should be taken due to its high potential to develop into a 
systemic infection in immune-compromised patients.
 3
 Oral presentations of 
candidiasis vary from the large white plaques of pseudomembraneous candidiasis to 
the palatal erythematous lesions of chronic atrophic candidiasis, and to angular 
cheilitis on the labial commissures .The primary etiological agent of oral candidiasis 
is the yeast C. albicans; however, other species that cause disease less commonly 
include C. tropicalis, C. glabrata, C. krusei, C parapsilosis, C. guilliermondii, and C. 
dubliniensis.
 
Candida species have become the fourth most common cause of nosocomial 
bloodstream infection since 1995 and with a crude mortality rate of 39%, which is the 
highest mortality rate associated with nosocomial bloodstream infections
4
. Sequelae 
of mucosal colonization, particularly of the gastrointestinal tract, includes penetration 
of the vascular system by Candida cells followed by hematogenous dissemination 
.These cells infect a variety of organs in immunocompromised individuals causing  
disseminated or systemic disease.  
The virulence factor of Candida has specific strategies to assist in 
colonization, invasion, and pathogenesis, and the virulence factor responsible for 
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causing the infections which may vary depending on the type of infection, the site and 
stage of infection, and the nature of the host response. 
5
 The main virulence factors 
are biofilms formation, phospholipase, production of acid proteinase, etc. Once the 
contact is made, enzymes facilitate adherence by damaging or degrading cell 
membranes and extracellular proteins thus permitting the yeast to enter the host, 
whereas phenotypic switching or coating with platelets may be used to evade the 
immune system.
1 
A broad variety of oral manifestations have been reported in ESRD patients 
including gingivitis, xerostomia, ammonia-like smell, mucosal pallor and lesions, 
tooth mobility, malocclusion  and an increased risk of dental erosion due to frequent  
regurgitation. Systemic and salivary changes due to chronic renal failure, the use of 
multiple medications, vomiting and reduced oral self care could all potentially affect 
oral health in these patients.
4
 However, despite its great clinical importance, little is 
known on the relationship between colonization in the oral cavity and infection by 
yeasts of patients with CKD undergoing HT.
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AIMS & OBJECTIVES 
 To assess the presence of Candidasis, Uremic Stomatitis, and Uremic frost in 
patients undergoing hemodialysis.   
 To assess the presence of various subspecies of Candida in patients with 
chronic renal disease undergoing hemodialysis. 
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The objective of this review is to provide an overview of renal failure and 
Candidasis, Uremic Stomatitis, and Uremic frost in terms of its classification, risk 
factors, pathophysiology, diagnosis and management. The common oral 
complications observed in renal failure  are discussed as well as the role of dentists  in  
diagnosis and management of oral complications in  a renal failure  patient is also 
reviewed here.  
STRUCTURE OF KIDNEY 
The human kidneys are bean-shaped organs located in the retroperitoneum at 
the level of the waist. Each adult kidney weighs approximately 160 g and measures 
10–15cm in length. Coronal sectioning of the kidney reveals two distinct regions: an 
outer region called cortex and an inner region known as the medulla .
8
 
Structures that are located at the corticomedullary junction extend into the 
kidney hilum and are called papillae Each papilla is enclosed by a minor calyx that 
collectively communicates with the major calyces to form the renal pelvis. The renal 
pelvis collects urine flowing from the papillae and passes it to the bladder via the 
ureters. Vascular flow to the kidneys is provided by the renal artery, which branches 
directly from the aorta. This artery subdivides into segmental branches to perfuse the 
upper, middle, and lower regions of the kidney. 
9
Further subdivisions account for the 
arteriole-capillary venous network or vas recta. The venous drainage of the  kidney is 
provided by a series of veins leading to the renal vein and ultimately to the inferior 
vena cava. 
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The kidney’s functional unit is the nephron and each kidney is made up of 
approximately one million nephrons. Each nephron consists of Bowman’s capsule, 
which surrounds the glomerular capillary bed; the proximal convoluted tubule; the 
loop of Henle; and the distal convoluted tubule, which empties into the collecting 
ducts. The glomerulus is a unique network of capillaries that is suspended between 
afferent and efferent arterioles enclosed within Bowman’s capsule and that serves as a 
filtering funnel for waste.
12
 The filtrate drains from the glomerulus into the tubule, 
which alters the concentration along its length by various processes to form urine. The 
glomerulus funnels ultrafiltrate to the remaining portion of the nephron or renal 
tubule. Following filtration, the second step of urine formation is the selective 
reabsorption and secretion of filtered substances, which occurs along the length of the 
tubule via active and passive transport processes.
10
 
Each day, the kidneys excrete approximately 1.5–2.5 L of urine; although the 
removal of toxic and waste products from the blood remains their major role, the 
kidneys are also essential for the production of hormones such as vitamin D and 
erythropoietin and for the modulation of salt and water excretion.  
Once destroyed, nephrons do not regenerate. However, the kidney 
compensates for the loss of nephrons by hypertrophy of the remaining functioning 
units. 
11
 Normal renal function can be maintained until approximately 50% of the 
nephrons per kidney are destroyed, at which point abnormal laboratory values and 
changes in the clinical course occur.  
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RENAL FAILURE 
The classification of renal failure is based on two criteria:the onset (acute 
vs.chronic failure) and the location that precipitates nephron destruction (prerenal, 
renal or intrinsic, and postrenal failure). CKD is a slow, irreversible, and progressive 
process that occurs over a period of years, whereas AKI develops over a period of 
days or weeks.
8
 The distinction between acute and chronic disease is important; acute 
disease is usually reversible if managed appropriately, whereas CKD is a progressive 
and irreversible process that leads to death in the absence of medical intervention. In 
both cases, the kidneys lose their normal ability to maintain the normal composition 
and volume of bodily fluids. 
ACUTE KIDNEY INJURY 
AKI is a clinical syndrome characterized by a rapid decline in kidney function 
over a period of days to weeks, leading to severe azotemia. It is very common in 
hospitalized patients; Sepsis, shock, medications, surgery, pregnancy-related 
complications, and trauma are the most common causes of AKI.
12
 Patients with AKI 
usually have normal baseline renal function, yet mortality from AKI (even with 
medical intervention including dialysis) can reach 80%, demonstrating the critical 
illness of these patients. The clinical course of AKI most often progresses through 
three stages: oliguria (urine volume <400 mL per day), diuresis (high urine volume 
output >400 mL per day), and, ultimately, recovery. The causes of AKI are often 
divided into three diagnostic categories: prerenal failure, postrenal failure, and acute 
intrinsic renal failure. 
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Prerenal Failure 
Prerenal failure, the most common cause of hospital-acquired renal failure is a 
condition that compromises renal function without permanent physical injury to the 
kidney. This condition, often referred to as prerenal azotemia, results from reversible 
changes in renal blood flow and is the most common cause of AKI, accounting for 
more than 50% of cases.
3
 Some etiologic factors commonly associated with prerenal 
failure include volume depletion, heart failure and cardiovascular shock, medications 
that perturb blood flow through the nephron, and changes in fluid volume distribution 
that are associated with sepsis and burns. 
Postrenal Failure 
Postrenal causes of failure are less common. Postrenal failure refers to 
conditions that obstruct the flow of urine from the kidneys at any level of the urinary 
tract and that subsequently decrease the GFR. Postrenal failure can cause almost total 
anuria, with complete obstruction or polyuria. Renal ultrasonography often shows a 
dilated collecting system (hydronephrosis). 
Acute Intrinsic Renal Failure 
 Glomerular disease, vascular disease, and tubulointerstitial disease comprise the 
three major causes of acute intrinsic renal failure. 
11 
Prominent clinical and laboratory 
findings include hypertension, proteinuria, microscopic hematuria, and red blood cell 
casts.  
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Post infectious, membranoproliferative, and rapidly progressive 
glomerulonephritis, as well as glomerulonephritis associated with endocarditis, are the 
most common glomerular diseases to cause a sudden renal deterioration. 
Vascular diseases that induce AKI cover the spectrum of vessel size from 
large (renal artery and vein) to the microscopic (afferent and efferent arterioles of the 
glomerulus). Large vessel occlusive processes such as renal arterial or venous 
thromboses present as a classic triad of severe and sudden lower back pain, severe 
oliguria, and macroscopic hematuria.
14
 Medium-to-small vasculature AKI is often 
caused by autoimmune vasculidities, thrombotic microangiopathies, or cholesterol 
crystal embolization. 
The most common causes of acute intrinsic failure are tubulointerstitial 
disorders, including interstitial nephritis and acute tubular necrosis (ATN). 
5
 
CHRONIC RENAL FAILURE  
 CKD can be caused by many diseases that devastate the nephron mass of the 
kidneys. Most of these conditions involve diffuse bilateral destruction of the renal 
parenchyma. Some renal conditions affect the glomerulus (glomerulonephritis), others 
involve the renal tubules (polycystic kidney disease or pyelonephritis), whereas others 
interfere with blood perfusion to the renal parenchyma (nephrosclerosis). Ultimately, 
nephron destruction ensues in all cases unless this process is interrupted.
14
  
CKD is divided into stages 1to 5 based on the current GFR. Patients with stage 
1 and 2 generally have“normal” renal function (GFR > 60 mL/min/1.73 m2) with 
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evidence of structural kidney dysfunction (proteinuria, glomerular hematuria, 
recovery from ATN, etc.). 
13
  
At stage 3 CKD, patients are usually referred to a nephrologist for evaluation 
and management. The extrarenal pathologies that accompany CKD (anemia, 
secondary hyperparathyroidism [HPTH], metabolic acidosis) may begin to manifest at 
this level of renal function (< 60 mL/min). Renally excreted medications generally 
need dose adjustment starting at this stage as well.
13
  
During late stage 4 (GFR < 30 mL/min/1.73 m2) disease or early stage 5 (GFR 
< 15 mL/min/1.73 m2) disease, patients often become symptomatic and may develop 
uremic symptoms, which include nausea, vomiting, weight loss,decreased appetite, or 
a metallic taste in the mouth. They may also manifest symptoms of excessive fluid 
retention, such as leg swelling, generalized edema, or shortness of breath due to 
pulmonary edema. Patients may also develop severe biochemical abnormalities, 
including severe anemia, hyperkalemia, metabolic acidosis, hyperphosphatemia, 
hypocalcemia, and increased parathyroid hormone levels.
14
 The complex biochemical 
changes, including anemia, hypocalcemia, hyperphosphatemia, and metabolic 
acidosis, together with systemic symptoms patients experience, are termed the 
“uremic syndrome.” At this point in the disease process, renal replacement therapy or 
dialysis is a necessity or death is a certain consequence. 
Diseases of the kidney are a major cause of morbidity and mortality. Renal 
failure expresses the loss of functional capacity of the nephrons independently of its 
etiology. Normal renal function can be maintained until approximately 50% of the 
nephrons per kidney are destroyed. ESRD occurs when the kidney function is 
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impaired towards 5-10% of the original capacity. 
16
A characteristic profile of changes 
occurs with advancing renal dysfunction, including elevations in serum creatinine, 
BUN, and phosphate, compared with low levels of serum calcium.  
For patients with ESRD, dialysis has significantly decreased the mortality. 
Most nephrologists will initiate dialysis when the GFR is <15 mL/min/1.73m2 and the 
patient is exhibiting hard uremic symptoms.  
There are two major techniques of dialysis: hemodialysis and peritoneal 
dialysis. Each follows the same basic principle of diffusion of solutes and water from 
the plasma to the dialysis solution in response to a concentration or pressure gradient. 
For advanced and permanent kidney failure hemodialysis is the most common method 
for treatment.
11 
But even with better procedures and equipment, hemodialysis is still a 
complicated and inconvenient therapy that requires a coordinated effort from whole 
health care team, including nephrologist, dialysis nurse, dialysis technician, dietitian, 
and social worker. The most important members of health care team are patient and 
their family 
CANDIDASIS  
  Candida albicans is a dimorphic yeast existing as blastoconidia (also termed 
blastospores or yeast cells), as pseudohyphae (a septate filamentous form) and as 
hypha (a non-septate filamentous form). These three forms differ in cell surface 
antigens, in cell attachment mechanisms and in growth potential.
2
 The evolution from 
the commensal blastoconidial stage to the filamentous pseudohypha or hypha stages is 
associated with tissue invasion and clinical infection, may be induced by 
microenvironmental changes and may be precipitated by local or systemic factors .It 
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has been reported that in up to 50% of healthy persons with apparently healthy oral 
and oropharyngeal mucosa, the mucosa is in fact colonized by C. albicans .The 
capacity of C. albicans to adhere to oral keratinocytes, to invade and to cause direct 
tissue damage, to evade host immune responses or to induce exaggerated harmful 
immuno-inflammatory responses, as well as the fitness of the specific C. albicans 
strain, are all critical factors determining the degree of virulence that the fungus 
possesses .
6
 
CLASSIFICATION OF CANDIDASIS 
  Oral candidiasis is classified using the Lehner system, originally described in 
the 1960s, into acute and chronic forms. Some of the subtypes almost always occur as 
acute (e.g., acute pseudo membranous candidiasis), and others chronic. 
Primary Oral Candidiasis                                   Secondary Oral Candidiasis 
Acute                                                    1. Familial chronic mucocutaneous candidiasis 
1. Pseudomembranous                          2.  Diffuse chronic mucocutaneous candidiasis 
2. Erythematous                                     3. Candidiasis   endocrinopathy syndrome 
                                                               4. Familial mucocutaneous candidiasis 
Chronic                                                 5.  Severe combined immunodeficiency 
1. Pseudomembranous                            6. DiGeorge syndrome 
2. Erythematous                                      7. Chronic granulomatous disease 
3. Plaque-like                                          8.Acquired immune deficiency syndrome  
4. Nodular 
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Candida-associated lesions 
1. Denture stomatitis 
2. Angular cheilitis 
3. Median rhomboid glossitis 
Pseudo membranous 
Acute pseudo membranous candidiasis is a classic  form of oral candidiasis; 
this is the most common type of oral candidiasis, accounting for about 35% of oral 
candidiasis cases. It is characterized by extensive white pseudo membranes consisting 
of desquamated epithelial cells, fibrin, and fungal hyphae these white patches occur 
on the surface of the labial and buccal mucosa, hard and soft palate, tongue, 
periodontal tissues, and or pharynx.
6
 The membrane can usually be scraped off with a 
swab to expose an underlying erythematosus mucosa. 
Erythematous 
Erythematous (atrophic) candidiasis is where the condition appears as a red, 
raw-looking lesion. Some sources consider denture-relatedstomatitis, angular 
stomatitis, median rhombiodglossitis, and antiobiotic-induced stomatitis as subtypes 
of erythematous candidiasis, since these lesions are commonly erythematous/ 
atrophic. It may precede the formation of a pseudo membrane, be left when the 
membrane is removed, or arise de novo.
9 
The erythematous candidiasis accounts for 
60% of oral candidiasis cases. Where it is associated with inhalation steroids, 
erythematous candidiasis commonly appears on the palate or the dorsum of the 
tongue. On the tongue, there is loss of the lingual papillae (depapillation), leaving a 
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smooth area on the tongue. Acute erythematous candidiasis usually occurs on the 
dorsum of the tongue in persons taking long  term corticosteroids or antibiotics, but 
occasionally it can occur after only a few days of using a topical antibiotic. This is 
usually termed antibiotic sore mouth “,” antibiotic sore tongue or "antibiotic induced 
stomatitis" because it is commonly painful as well as red. Chronic erythematous 
candidiasis is more usually associated with denture wearing.
19
 
Hyperplastic 
This variant is also sometimes termed "plaque-like candidiasis" or "nodular 
candidiasis". The most common appearance of hyperplastic candidiasis is a persistent 
white plaque that does not rub off. The lesion may be rough or nodular in texture. 
Hyperplastic candidiasis is uncommon, accounting for about 5% of oral candidiasis 
cases and is usually chronic and found in adults. The most common site of 
involvement is the commisural region of the buccal mucosa, usually on both sides of 
the mouth. Another term for hyperplastic candidiasis is "candidal leukoplakia". This 
term is a largely historical synonym for this subtype of candidiasis, rather than a true 
leukoplakia. It can be clinically indistinguishable from true leukoplakia, but tissue - 
biopsy shows candidal hyphae invading the epithelium.
24
 Some sources use this term 
to describe leukoplakia lesions that become colonized secondarily by Candida 
species, thereby distinguishing it from hyperplastic candidiasis. It is known that 
Candida resides more readily in mucosa that is altered, such as may occur with 
dysplasia and hyperkeratosis in an area of leukoplakia. 
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Associated lesions 
Angular cheilitis 
Angular cheilitis is inflammation in  the corners (angles) of the mouth, very 
commonly by Candida species, when sometimes the terms "Candida-associated 
angular cheilitis", or less commonly, "monilialperlèche" are used.
6
 Candida organisms 
alone responsible for about 20% of cases, and a mixed infection of C. albicans and 
Staphylococcus aureus for about 60% of cases. Signs and symptoms include soreness, 
erythema (redness), and fissuring of one, or more commonly boththe angles of the 
mouth, with edema seen intraorally on the commisures. Angular cheilitis is generally 
occurs in elderly people and is associated with denture related stomatitis. 
Denture related stomatitis 
This term refers to a mild inflammation with  erythema of the mucosa beneath 
a denture, usually  an upper denture in elderly edentulous individuals (with no natural 
teeth remaining). Some report that up to 65% of denture wearers have this condition 
to some degree. Other terms include  "candida-associated denture stomatitis, “or” 
Candida-associated denture induced stomatitis" (CADIS).
19
 Some sources state that 
this is by far the most common form of oral candidiasis. Although this condition is 
also known as "denture sore mouth", there is rarely any pain. Candida is associated 
with about 90% of cases of denture related stomatitis. 
Median rhomboid glossitis 
This is an elliptical or rhomboid lesion in the center of the dorsal tongue, just 
anterior (in front) of the circumvallate papillae.
24
 The area is reddened, depapillated 
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and rarely painful. There is frequently Candida species in the lesion, sometimes mixed 
with bacteria  
 Chronic multifocal oral candidiasis 
This is an uncommon form of chronic (more than one month in duration) 
candidial infection involving multiple areas in the mouth, without signs of candidiasis 
on other mucosal or cutaneous sites. 
9
The lesions are variably red and/or white, and it 
occurs in apparently healthy individuals, normally elderly males. Smoking is a known 
risk factor. 
Chronic mucocutaneous candidiasis 
This refers to a group of rare syndromes characterized by chronic candidal 
lesions on the skin, in the mouth and on other mucous membranes (i.e., a secondary 
oral candidiasis). These include diffuse mucocutaneous candidiasis (Candida 
granuloma), candidiasis-endocrinopathy syndrome, localized chronic mucocutaneous 
candidiasis, and candidiasis thymoma syndrome. About 90% of people with chronic 
mucocutaneous candidiasis have candidiasis in the mouth. 
UREMIC STOMATITIS  
Represents an uncommon intraoral complication, mostly, in cases of end-stage 
renal disease or undiagnosed/untreated chronic renal failure. Etiology of this remains 
unknown although it has been suggested that it may be due to raised levels of 
ammonia compounds. Ammonia is formed through the action of bacterial ureases 
modifying salivary urea which may be raised in affected individuals.
31
 It has been 
suggested that stomatitis appears when blood urea levels are higher than 300 mg/ml, 
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although some cases reported mucosal changes at urea levels of less than 200 mg/ml. 
Other possible causes include hemorrhagic diathesis, common in uremia, causing 
decrease of viability of the affected tissues allowing bacterial infection, which can 
result in ulceration and pseudomembrane formation.
44 
Four forms are recognized: ulcerative form, hemorrhagic form, nonulcerative 
pseudomembranous form and hyperkeratotic form. Last two forms are commonly 
seen and appear as white lesions. 
31
The hyperkeratotic form presents as multiple, 
painful white keratotic lesions with thin projections. Nonulcerative form may appear 
as erythemopultaceous form characterized by red mucosa covered with a thick 
exudates and a pseudomembrane. Tongue and floor of mouth are usually affected. 
UREMIC FROST 
  Uremic frost is a manifestation of advanced CKD the incidence of uremic frost 
to be 3%. When the BUN level is high, the concentration of urea in sweat increases 
greatly. Evaporation of sweat with high urea concentration causes urea to crystallize 
and deposit on the skin. 
52
The frost consists of a white or yellowish coating of urea 
crystals on the beard area and other parts of the face, neck and on the trunk. It is due 
to eccrine deposition of urea crystals on the skin surface of patients with severe 
uremia. 
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RISK FACTORS 
1. RENAL FAILURE 
a. GFR AND RENAL PROGRESSION 
A reduction in GFR is a marker and a risk factor for renal progression. For 
moderate CKD the hazard ratio (HR) was 2.02 with a 95% confidence interval (95% 
CI) 1.67 – 2.46; and for severe CKD the HR was 6.84 with a 95% CI 5.59 – 8.37. 18 
GFR measurement by inulin clearance is the gold standard. GFR measurement by 
iohexol plasma disappearance method has been validated by the CKD study as an 
accurate, reproducible, non-radioactive and safe method for the measurement of GFR 
in children.  
b.Proteinuria and renal progression 
In human studies, elevated urine total protein is shown to be an independent 
risk factor for more rapid decline in kidney function. When there is increase in urinary 
protein it causes injury to tubular cells, leading to interstitial inflammation and 
fibrosis.
23
 In patients with CKD, blockade of the renin-angiotensin system (RAS) 
reduces proteinuria:in adults, 1g/day reduction in proteinuria is associated with an 
abatement of GFR decline by 1-2mL/min per year.  
c. Hypertension and renal progression 
Systemic hypertension causes intraglomerular hypertension leading to 
glomerular hypertrophy and injury.  In the multivariable analysis (adjusting for age, 
race, GFR, CKD diagnosis, duration of CKD, antihypertensive use, obesity, and 
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serum potassium), African American race, elevated serum potassium, longer duration 
of CKD, and antihypertensive use are the  independent risk factors for BP elevation.
18 
d. Anemia and renal progression 
Anemia is caused by decrease in renal production of Erythropoietin. The 
prevalence rate is approximately 30% in the earlier stages of CKD (stages 1 and 2), 
the rate of anemia was 66% at moderate CKD (stage 3), and 93% with severe CKD 
and end stage renal disease (ESRD). Multiple studies have found anemia to be 
associated with an increased risk of morbidity and mortality.
3
 
e. Other risk factors for renal progression 
Other reported risk factors associated with CKD progression include  uric 
acid, lead or heavy metals, hyperlipidemia, metabolic acidosis, oxidative stress, and 
disorders of bone and mineral metabolism .  
2. ORAL CANDIDIASIS 
(1) Pathogenesis 
Candida is a fungus and was first isolated in 1844 from the sputum of a 
tuberculous patient. They are eukaryotic non-photosynthetic organisms with a cell 
wall that lies external to the plasma membrane. There is a nuclear pore complex 
within the nuclear membrane. The plasma membrane contains large quantities of 
sterols, usually ergosterol.
25
 Apart from a few exceptions, the macroscopic and 
microscopic cultural characteristics of the different candida species are similar. 
Temperature influences their growth with higher temperatures such as 37°C that are 
present in their potential host, promoting the growth of pseudohyphae. They can be 
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found on or in the human body with the gastrointestinal tract, the vagina, and skin 
being the most common sites and C albicans being the commonest species isolated 
from these sites.
26
 Filamentous growth and apical extension of the filament and 
formation of lateral branches are seen with hyphae and mycelium, and single cell 
division is associated with yeasts. Adhesion of candida to epithelial cell walls, is 
promoted by certain fungal cell wall components such as mannose, C3d receptors, 
mannoprotein, and saccharins.The degree of hydrophobicity and ability to bind to host 
fibronectin has also been reported to be important in the initial stages of infection. 
Phenotypic switchingwhich is the ability of certain strains of C albicans to 
changebetween different morphologic phenotypes has also been implicated. 
(2) Host 
Local factors 
Impaired salivary gland function can predispose to oral candidiasis. 
Antimicrobial proteins in the saliva such as lactoferrin, sialoperoxidase, lysozyme, 
histidine-rich polypeptides, and specific anticandida antibodies, interact with the oral 
mucosa and prevent overgrowth of candida. Drugs such as inhaled steroids have been 
shown to increase the risk of oral candidiasis by possibly suppressing cellular 
immunity and phagocytosis.
27
 Dentures predispose to infection with candida in as 
many as 65% of elderly people wearing full upper dentures. Dentures produce a 
microenvironment to the growth of candida with low oxygen, low pH, and an 
anaerobic environment. This may be due to enhanced adherence of Candida spp to 
acrylic, reduced saliva flow under the surfaces of the denture fittings, improperly 
fitted dentures, or poor oral hygiene. 
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Systemic factors extremes of life predispose to infection because of reduced 
immunity. Drugs such as broad spectrum antibiotics alter the local oral flora. 
28
The 
normal oral flora is restored once the antibiotics are discontinued. Immunosuppressive 
drugs such as the antineoplastic agents have been shown in several studies to 
predispose to oral candidiasis by altering the oral flora, disrupting the mucosal surface 
and altering the character of the saliva. 
PATHOGENESIS 
A. RENAL FAILURE  
The progression ranges from a few months to years. Currently,diabetes and 
hypertension account for 44.4% and 26.6%,respectively, ofthe total cases of ESRD. 
Glomerulonephritis is the third most common cause of ESRD (12.2% of 
cases).Interstitial nephritis, pyelonephritis, and polycystic kidney disease account for 
7.2% of cases. Age, race, gender, and family history have been identified as risk 
factors for the development of ESRD.
1
 People of Asian ancestry make up 
2.9%.Family history is a risk factor for diabetes and hypertension, both of which 
adversely affect the kidneys and therefore constitute a risk for developing ESRD. 
Recent evidence suggests that smoking is a major renal risk factor, increasing the risk 
of nephropathy and doubling the rate of progression to endstage disease. 
B. ORAL CANDIDIASIS  
C. albicans, C. tropicalis, and C. glabrata comprise 80% of the species isolated 
from human candidal infections. To invade the mucosal lining, the microorganisms 
must adhere to the epithelial surface; therefore, candidal strains with better adhesion 
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potential are more virulent than strains with poorer adhesion ability. The yeasts’ 
penetration  is  facilitated by their production of lipases. The local predisposing 
factors are able to promote growth of the yeast or to affect the immune response of the 
oral mucosa.
6
 General predisposing factors are related to individual’s immune status 
and endocrine status. Drugs as well as diseases, which suppress the adaptive or the 
innate immune system, can affect the susceptibility of the mucosal lining.  
B.UREMIC STOMATITIS  
The etiology of uremic stomatitis remains unknown, although it has been 
suggested that it may be the consequence of raised levels of ammonia compound. 
Ammonia is formed through the action of bacterial ureases modifying salivary urea, 
which can be elevated in affected patients. It has been suggested that stomatitis 
appears when blood urea levels are higher than 300 mg/mL, although, there have been 
reports of mucosal changes at urea levels of less than 200 mg/mL.
31
  
D.UREMIC FROST 
When the BUN level is high, the concentration of urea in sweat increases 
greatly. Evaporation of sweat with highurea concentration causes urea to crystallize 
and deposit on the skin. The frost consists of a white or yellowish coating of urea 
crystals. It is due to eccrine deposition of urea crystals on the skin surface of patients 
with severe uremia.
44 
Establishing the diagnosis of Renal Failure  
Diagnosing renal failure is the realm of the physician
 
as oral health care 
providers are not qualified to make a diagnosis. But, it is still important for dentists to 
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understand how the diagnosis is reached since they have a significant role to play in 
identifying the persons at risk or those who may have undiagnosed renal failure. 
17 
Several tests can be employed in order to diagnose renal failure but the main methods 
are as follows.
 
In the presence of renal dysfunction, changes in homeostasis are reflected in 
serum chemistry. Serum creatinine and BUN is often important marker to the GFR. A 
characteristic profile occurs with advancing renal dysfunction, including elevations in 
serum creatinine, BUN, and phosphate, compared with low levels of serum calcium.
29
  
The hallmarks of renal dysfunction detected by urinalysis are hematuria and 
proteinuria. 
 
Ultrasonography is the most commonly used and relied-upon radiologic 
examination of the kidneys.  CT imaging is utilized when the entire genitourinary 
(GU) tract or retroperitoneum needs evaluation. 
IV pyelography was the most commonly used and relied upon radiologic 
examination of the kidneys. Following the IV injection of a contrast medium, a plain-
film abdominal radiograph is taken. Further films are exposed every minute for the 
first5 minutes, followed by 15 minutes and finally at 45 minutes. Since various 
diseases alter the  ability to concentrate and excrete the dye, the extent of renal 
damage can be assessed.
11 
Radionuclide scintigraphy can provide functional information about the 
kidneys. Using radiolabeled tracers, information can be garnered about renal blood 
flow, glomerular filtration,or urinary excretion. Radionuclide scintigraphy is the 
method  of choice to measure GFR in patients who have undergone a spinal injury, as 
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serum creatinine is linked to muscle mass, which may be disproportionately lower in 
this patient population. 
 
The development and growing use of renal biopsy have considerably advanced 
the knowledge of the natural history of kidney diseases.
29
 Percutaneous needle biopsy 
guided by ultrasonographic or radiographic reference is usually performed by 
nephrologists.
 
Diagnosis of Oral Candidiasis 
The presence of candidal microorganisms complicates the discrimination of 
the normal state from infection. Sometimes antifungal treatment has to be initiated to 
assist in the diagnostic process. 
Smear from the infected area comprising epithelial cells, creates opportunities 
for detection of the yeasts. The detection of yeast organisms in the form of hyphae- or 
pseudohyphae-like structures is usually considered a sign of infection although these 
structures have also been identified in normal oral mucosa.
36
 This technique is useful 
when pseudomembranous oral candidiasis and angular cheilitis are suspected. To 
increase the sensitivity, a second scrape can be transferred to a transport medium 
followed by cultivation on Sabouraud agar.
27
 Imprint culture technique can also be 
used where sterileplastic foam pads (2.5 × 2.5 cm) are submerged in Sabouraud broth 
and placed on the infected surface for 60 seconds. The pad is firmly pressed onto 
Sabouraud agar, which will be cultivated at 37°C. The result is expressed as colony 
forming units per cubic millimeter (CFU/mm2). This method is a valuable adjunct in 
the diagnostic process of erythematosus candidiasis and denture stomatitis as these 
infections consist of fairly homogeneous erythematous lesions. Salivary culture 
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techniques are used in parallel with other diagnostic methods to obtain an adequate 
quantification of candidal organisms. Patients who display clinical signs of  oral 
candidiasis usually have more than 400 CFU/mL.In chronic plaque-type and nodular 
candidiasis, cultivation techniques have to be supplemented by a histopathologic 
examination.
39
 This examination is performed to identify the presence of epithelial 
dysplasia and to identify invading candidal organisms by PAS staining. However, for 
the latter, there is a definitive risk of false-negative results. 
Diagnosis of uremic stomatitis 
Uremic stomatitis, appear as an erythemopultaceous form characterized by red 
mucosa covered with a thick exudate and a pseudomembrane or as an ulcerative form 
characterized by frank ulcerations with redness and a pultaceous coat.
31
 These 
intraoral lesions have been related to BUN levels >150 mg/dl and disappear 
spontaneously when medical treatment results in a lowered BUN level. Uremic 
stomatitis can be regarded as a chemical burn or as a general loss of tissue resistance 
and inability to withstand normal and traumatic influences. 
Diagnosis of uremic frost 
Uremic frost results from residual urea crystals left on the epithelial surfaces 
after perspiration evaporates or as a result of decreased salivary flow.
44 
MANAGEMENT 
The treatment of CKD is often divided into (1) conservative therapy aimed at 
delaying progressive renal dysfunction and (2) renal replacement therapy, instituted 
when conservative measures are no longer effective in sustaining life. 
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CONSERVATIVE THERAPY 
Initial conservative therapy is directed toward managing diet, fluid, 
electrolytes, and calcium–phosphate balance and toward the prevention and treatment 
of complications. Dietary modifications are initiated with the onset of uremic 
symptoms. A practical clinical approach to the management of patients with CKD, 
using BEANS (blood pressure, erythropoietin, access to dialysis, nutritional status, 
specialty evaluation by a nephrologist), has gained popularity Blood pressure should 
be maintained in a target range lower than 130/80 mm Hg. Hemoglobin levels should 
be maintained at 10–12 g/dL with erythropoietin-stimulating agents. Hyperlipidemia 
should be treated with a “statin” lipid-lowering medication.34 Smoking cessation 
should also be encouraged. Access to dialysis should be created when the serum 
creatinine reaches >4.0 mg/dL or the GFR decreases to <20 mL/min/1.73 m2. Close 
monitoring of nutritional status is important to avoid protein malnutrition, correct 
metabolic acidosis, prevent and treat hyperphosphatemia, administer vitamin 
supplements,and guide the initiation of dialysis therapy.
48 
RENAL REPLACEMENT THERAPY 
There are no clear guidelines for determining when renal replacement therapy 
should begin. Most nephrologists base their decisions on the individual patient’s 
ability to work full time, the presence of peripheral neuropathy, and the presence of 
other signs of clinical deterioration or uremic symptoms. Most nephrologists will 
initiate dialysis when the GFR is <15mL/min/1.73m
2
 and the patient is exhibiting 
hard uremic symptoms. There are a number of absolute clinical indications to initiate 
maintenance dialysis.
49
 These include pericarditis, fluid overload or pulmonary edema 
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refractory to diuretics, accelerated hypertension poorly responsive to antihypertensive 
medications, progressive uremic encephalopathy or neuropathy, clinically significant 
bleeding attributable to uremia, and persistent nausea and vomiting. There are two 
major techniques of dialysis: hemodialysis and peritoneal dialysis. Each follows the 
same basic principle of diffusion of solutes and water from the plasma to the dialysis 
solution in response to a concentration or pressure gradient. 
HEMODIALYSIS 
Hemodialysis is the removal of nitrogenous and toxic products of metabolism 
from the blood by means of a hemodialyzer system. Exchange occurs between the 
patient’s plasma and dialysate (the electrolyte composition of which mimics that of 
extracellular fluid) across a semipermeable membrane that allows uremic toxins to 
diffuse out of the plasma while retaining the formed elements and protein composition 
of blood.
23
 Dialysis therapy can be delivered to the patient in outpatient dialysis 
centers, where trained personnel administer therapy on a regular basis, or in the home, 
where family members trained in dialysis techniques assist the patient in dialysis 
therapy. The frequency and duration of dialysis treatments are related to body size, 
residual renal function, protein intake, and tolerance to fluid removal. The typical 
patient undergoes hemodialysis three times per week, with each treatment lasting 
approximately three to four hours on standard dialysis units and slightly less time on 
high-efficiency or high-flux dialysis units.During treatments and for varying amounts 
of time afterward, anticoagulants are administered by regional or systemic methods. 
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PERITONEAL DIALYSIS 
During peritoneal dialysis, access to the body is achieved via a catheter 
through the abdominal wall into the peritoneum. One to two liters of dialysate is 
placed in the peritoneal cavity and is allowed to remain for varying intervals of time. 
29
Substances diffuse across the semipermeable peritoneal membrane into the 
dialysate. Compared with the membranes used for hemodialysis, the peritoneal 
membrane. Several regimens can be used with peritoneal dialysis. In one chronic 
ambulatory peritoneal dialysis, 2 L of dialysis fluid is instilled into the peritoneal 
cavity, allowed to remain for 30 minutes, and then drained out. This is repeated every 
8–12 hours, 5–7 days per week. A popular variation of this is continuous cyclic 
peritoneal dialysis, in which 2–3 L of dialysate is exchanged every hour over a 6- to 
8-hour period overnight, 7 days per week. Two of the benefits of peritoneal dialysis 
are that heparinization is unnecessary and that there is no risk of air embolism and 
blood leaks. It also allows a great deal of personal freedom; for this reason, it is often 
used as the primary therapy or a temporary measure. 
49
These features, along with its 
simplicity, make peritoneal dialysis safe for patients who are at risk when 
hemodialysis is used (e.g., the young, elderly patients, those with high-risk coronary 
and cerebral vascular disease, and those with vascular access problems). Some of the 
problems encountered with peritoneal dialysis are pain, intra-abdominal hemorrhage, 
bowel infarction, inadequate drainage, leakage, and peritonitis. 
Renal transplantation is the treatment of choice  for patients with irreversible 
kidney failure. However, the use of transplantation is limited by organ availability. 
GVHD is a unique complication of transplantation. In the oral cavity, this process 
clinically resembles lichenoid inflammation/ lichen planus.
20
 Oral GVHD appears as 
Review of Literature 
  30 
 
an area of wispy hyperkeratosis on an erythematous base in various areas of the oral 
mucosa. In severe GVHD, the lesions may be eroded .These ulcerations may serve as 
amport of entry for oral pathogens. There is also an increasing incidence of oral and 
esophageal squamous cell carcinoma in patients who have chronic GVHD after 
transplantation.GVHD not only affects the mouth but also the entire gastrointestinal 
system, as well as the skin and the liver. This reactioncan be lethal, and acute disease 
requires urgent treatment.
21 
However, chronic GVHD may be considered somewhat beneficial if it 
functions as a graft-versus-leukemia reaction, an immunologic process that eliminates 
persistent leukemic cells. Oral GVHD is challenging to treat and may require a 
change in the immunosuppressive regimen and the implementation of systemic or 
topical mucosal therapy for effective management. Some authors have used topical 
CSA or topical thalidomide gel in a bioadhesive base with good results. Ultraviolet B 
irradiation as well as ultraviolet A irradiation with oral psoralen (PUVA) has also 
been reported to be effective. A novel approach for treating oral GVHD involves the 
use of topical tacrolimus and AZA.
22 
Management Of Oral Candidiasis 
Treatment for fungal infections, which usually include antifungal regimens, 
will not always be successful unless the clinician addresses predisposing factors that 
may cause recurrence. Local factors are often easy to identify but sometimes not 
possible to reduce or eradicate. Antifungal drugs have aprimary role in such cases.  
The most commonly used antifungal drugs belong to the groups of polyenes or 
azoles. Polyenes such as nystatin and amphotericin B are usually the first choices in 
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treatment of primary oral candidiasis and are both well tolerated. Polyenes are not 
absorbed from the gastrointestinal tract and are not associated with development of 
resistance.
38
They exert the action through a negative effect on the production of 
ergosterol, which is critical for the yeast’s cell membrane integrity. Polyenes can also 
affect the adherence of the fungi. Whenever possible, elimination or reduction of 
predisposing factors should always be the first goal for treatment of denture stomatitis 
as well as other opportunistic infections.This involves improved denture hygiene and 
a recommendation not to use the denture while sleeping. The denture hygiene is 
important to remove nutrients, including desquamated epithelial cells, which may 
serve as a source of nitrogen, which is essential for the growth of the yeasts.Denture 
cleaning also disturbs the maturity of a microbial environment established under the 
denture. As porosities in the denture can harbor microorganisms, which may not be 
removed by physical cleaning, the denture should be stored in antimicrobial solutions 
during the night. 
42
Different solutions,including alkaline peroxides, alkaline 
hypochlorites, acids, disinfectants, and enzymes, have been suggested. The latter 
seems to be most effective against candidal strains.Chlorhexidine may also be used 
but can discolor the denture and also counteracts the effect of nystatin. 
Type III denture stomatitis may be treated with surgical excision in an attempt 
to eradicate microorganisms present in the deeper fissures of the granular tissue. If 
this is not sufficient, continuous treatment with topical antifungal drugs should be 
considered. Patients with no symptoms are rarely motivated for treatment, and the 
infection often persists without the patients being aware of its presence. However, the 
chronic inflammation may result in increased resorption of the denture-bearing bone. 
43
Topical treatment with azoles such as miconazole is the treatment of choice for 
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angular cheilitis often infected by both S. aureus and candidal strains. This drug has a 
biostatic effect on S. aureus in addition to the fungistatic effect. Retapamulin can be 
used as a complement to the antifungal drugs. 
If angular cheilitis comprises an erythema surrounding the fissure, a mild 
steroid ointment may be required to suppress the inflammation. To prevent 
recurrences, patients have to apply a moisturizing cream, which may prevent new 
fissure formation. Systemic azoles may be used for deeply seated primary candidiasis, 
such as chronic hyperplastic candidiasis,denture stomatitis, and median rhomboid 
glossitis with a granular appearance, and for therapy-resistant infections, mostly 
related to compliance failure. 
35
There are several disadvantages with the use of azoles. 
They are known to interact with warfarin, leading to an increased bleeding propensity. 
This adverse effect may also be present with topical application as the azoles are fully 
or partly resorbed from the gastrointestinal tract.  
Development of resistance is particularly compelling for fluconazole in 
individuals with HIV disease. In such cases, ketoconazole and itraconazole have been 
recommended as alternatives. However, cross-resistance has been reported between 
fluconazole on the one hand and ketoconazole, miconazole, and itraconazole on the 
other. The azoles are also used in the treatment of secondary oral candidiasis 
associated with systemic predisposing factors and for systemic candidiasis. 
47
 
Prognosis of oral candidiasis is good when predisposing factors associated 
with the infection are reduced or eliminated. Persistent chronic plaque-type and 
nodular candidiasis have been suggested to be associated with an increased risk for 
malignant transformation compared with leukoplakia, not infected by candidal strains. 
Review of Literature 
  33 
 
Patients with primary candidiasis are also at risk if systemic predisposing factors arise 
emerge.
51
 For example, patients with severe immunosuppression as seen in 
conjunction with leukemia and AIDS may encounter disseminating candidiasis with a 
fatal course. 
Management of uremic frost 
The treatment is dialysis and the prognosis is grave, as its presence signifies 
severe azotemia. 
Management of uremic stomatitis 
Uremic stomatitis responds to treatment of underlying renal failure. 
Additionally, local measures aimed at improving oral hygiene may also be used. 
CHRONIC RENAL FAILURE AND THE ORAL HEALTH STATUS 
The oral manifestations observed are like anemia, altered taste, xerostomia, 
gingival enlargement, parotitis, delayed eruption, enamel hypoplasia, and various 
mucosal lesions like hairy leukoplakia, lichenoid reactions, ulcerations, angular 
chelitis, candidiasis etc. With growing awareness about the inter-relationship between 
dental and medical problems, the role of dentist has become pivotal in overall health 
care of patients with CKD to render services for the oral findings of such diseases. 
Hematologic Problems 
Patients with CKD often have an underlying anemia, which runs parallel to the 
degree of renal insufficiency. The anemia caused by renal dysfunction is 
multifactorial and impacts both the manufacture and longevity of erythrocytes. 
49
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nephrons produces erythropoietin in response to hypoxic stress, which triggers 
increased production of erythrocyte from the bone marrow. As kidney disease 
progresses (often when GFR < 30 mL/min/1.73 m2), erythropoietin production is 
likewise truncated, and a normocytic, normochromic anemia ensues (anemia of 
chronic disease). Nutritional deficiencies, iron metabolism abnormalities, and uremic 
toxins also inhibit erythropoiesis through various mechanisms. Erythrocyte lifespan is 
shortened by the suboptimal living environment created by the multiple metabolic 
abnormalities that manifest in CKD as well. Lower body pH, intravascular fluid 
hypertonicity, hypertension, and retention of uremic waste products all contribute to 
an accelerated destruction of erythrocytes. Another cause of anemia in many dialysis 
patientsis the frequent blood sampling .
29 
These patients may also have a microcytic hypochromic anemia that may be 
caused by deficiencies in iron stores. Interestingly, these patients tolerate their anemia 
quite  well. Red blood cell transfusions are usually unnecessary, with the exception of 
cases of significant surgical blood loss or when the patient exhibits severe symptoms 
of anemia. These symptoms and signs of anemia may include pallor, tachycardia, 
systolic ejection murmur, a widened pulse pressure, and angina pectoris (in patients 
with underlying coronary artery disease). 
Uremic Stomatitis 
Uremic stomatitis is due to presence of markedly elevated levels of urea and 
other nitrogenous wastes in the blood stream which can be abrupt in onset. It 
represents as white plaques distributed predominantly on the buccal mucosa, floor of 
the mouth and tongue. Symptoms include pain, unpleasant taste and burning sensation 
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with the lesions, and the clinician may detect an odor of ammonia or urine in the 
patient’s breath. The clinical appearance mimic oral hairy leukoplakia. Uremic 
stomatitis is of four types such as Erythemopultaceous, Ulcerative, Hemorrhagic and 
Hyperkeratotic.
44 
Dry mouth 
Xerostomia or dry mouth, is a frequent and important complaint among 
chronic renal failure patients. There are several reasons for the prevalence of dry 
mouth. The decreased salivary flow is due to direct uremic involvement of salivary 
glands, chemical inflammation, dehydration, mouth breathing and also from the 
restricted fluid intake, irrespective of whether the patient is diabetic or not. The other 
conditions are retrograde parotitis, metabolic abnormalities and use of diuretics.
29 
Taste change 
The cause of metallic taste in uremic patients has been reported to be due to 
urea content in the saliva and its subsequent breakdown to ammonia and carbon 
dioxide by bacterial urease. The change in taste is due to metabolic disturbance, the 
use of medication, diminished number of taste buds and changes in the salivary flow 
and composition.  
Mucosal Petechiae and Ecchymosis 
The abnormal thrombocyte function result in this manifestation and a decrease 
in platelet factor III. It may also relate to the anticoagulants used during hemodialysis.  
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Renal Osteodystrophy 
A frequent long-term complication of renal disease is renal osteodystrophy, a 
spectrum of bone metabolism disorders associated with different pathogenic 
pathways. The patients are  prone  to fracture during dental treatments, such as 
extractions.
49
 Diffuse involvements of the jaws occur with radiographic alterations of 
the facial skeleton may represent one of the earliest signs of the disease. 
Some patients, marked jaw enlargement and malocclusion may occur. 
 Delayed eruption 
 Enamel hypoplasia  
 Loss of the lamina dura 
 Widening of the periodontal ligament 
 Severe periodontal destruction 
 Tooth mobility 
 Drifting 
 Pulp calcifications 
Candidiasis 
Candidal infection may present as angular cheilitis, pseudomembranous or 
erythematous ulceration or chronic atrophic infection. Prevention is effective in the 
early post transplant period with antifungal lozenges or solutions. Lozenges may cure 
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mild infections, but oral antifungal(1% topical clotrimazole) may be required.
38
 Viral 
infection, such as herpes simplex virus used to be common in transplant recipients; 
the use of antiherpetic agents, such as acyclovir(5%) has significantly reduced the 
frequency of these infections. 
Mucosal Lesions 
Oral mucosal lesions, white patches and ulceration have been noticed 
particularly in renal patients who are receiving dialysis and renal transplant. In 
particular, lichenoid reactions and oral hairy leukoplakia can occur. Epstein-Barr virus 
(EBV) has also been detected with uremia, which can resolve with correction of the 
uremia. White patches of the skin ,“uremic frost” is due to deposition of urea crystals 
on the epithelial surfaces following perspiration. It is seen intraorally, due to saliva 
evapouration.
52 
Periodontal Disease 
Gingival hyperplasia, increased levels of plaque, calculus, gingival 
inflammation and increased prevalence and severity of destructive periodontal 
diseases can be seen in patients with CKD. Gingival overgrowth involve  the interden-
tal papilla, marginal and attached gingiva and treatment frequently involves surgical 
resection.
31
 However, improved oral hygiene decrease the incidence or delay the onset 
of gingival hyperplasia. Platelet dysfunction and due to the effects of anticoagulants, 
gingival bleeding, petechiae and ecchymosis, result in CKD patients.  
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1. A study was done in 46 subjects undergoing hemodialysis and showed 22 
patients were colonized by yeast, all belonging to the genus Candida. Among   
22 patients, 13 of them presented with oral lesions.
3
 
2. A study was conducted to compare the frequency and severity of Oral  
Candida colonization in 60 patients with chronic renal failure admitted to a 
low intensity care unit with those in  age and sex matched controls by taking 
swabs from tongue and buccal mucosa. They concluded that in chronic renal 
failure there is a predisposition to oral candidiasis.
4
 
3. A study was done in 146 subjects undergoing hemodialysis and showed 57 
patients were colonized by yeast.
5
 
4. A study was conducted to find out the various oral manifestations in sample of 
70 chronic renal failure patients, divided into controlled and uncontrolled 
patients. Medical history and stomatological data were recorded and chronic 
renal failure patients were matched to uncontrolled patients. The main 
symptoms that researchers observed were hyposalivation, taste alterations and 
burning mouth .The lesions observed were candidiasis of the erythematous 
type and proliferative lesions both associated to the use of total prosthesis. No 
pathognomic lesions or alterations could be observed in relation to the disease. 
The frequency of carriers of Candida albicans and also the lesions observed 
could be compared to normal patients also using total denture.
25
 
5. A study was done in 400 cancer patients in which high incidence of oral 
candidiasis was seen in head and neck cancer.
7
  
6. A study was done in 49 subjects on hemodialysis and 50 subjects on kidney 
transplant recipients and showed Candida isolation was more significant in 
patients on hemodialysis and    kidney transplant recipients.
2
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7. A study was done to identify Candida species from various clinical specimens 
in which Candida albicans is the predominant species. They concluded that 
accurate species identification is important for the treatment, not all species 
respond to the same treatment and also because of the problem of antifungal 
resistance.
6
 
8. A study was done to investigate oral disorders and to compare the findings. 
Mucosal diseases, tooth loss, and temporomandibular joint dysfunction were 
examined in 45 patients with chronic renal failure and in 77 control subjects.
31
 
9. A study with the aim of studying oral health in patients with chronic renal 
failure was carried out in 102 randomly sampled chronic renal failure patients 
and 102 age and gender matched chronic renal failure subjects from the same 
geographical area. Oral conditions were examined clinically and 
radiographically. They found out that chronic renal failure  patients suffered 
from xerostomia to a significantly higher degree than controls did. chronic 
renal failure  subjects also showed a greater requirement of periodontal 
treatment, caries prevention and prosthetic rehabilitation. Patients with longer 
duration of chronic renal failure had more manifest caries lesions when 
compared with patients on oral/diet or combined treatment. They concluded 
that individuals with chronic renal failure in some oral conditions exhibited 
poorer health.
54
 
10. A study was conducted to determine the prevalence and characteristics of oral 
soft tissue diseases identified during a comprehensive oral evaluation of 405 
adult subjects with chronic renal failure and 268 control subjects without 
chronic renal failure. Subjects with chronic renal failure had significantly 
higher prevalence for fissured tongue, irritation fibroma, and traumatic ulcers. 
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They also found out that there were no differences found between the subjects 
with chronic renal failure and the control subjects for lichen planus, gingival 
hyperplasia, or salivary gland disease. Hence  they concluded that oral soft 
tissue lesions were seen more frequently in subjects with chronic renal failure 
than in the control subjects.
41
                                                     
11. A study was conducted to compare the prevalence of candidiasis in 405 
subjects with chronic renal failure and 268 control subjects. Subjects with 
chronic renal failure were found to have clinical manifestations of candidiasis, 
including median rhomboid glossitis, denture stomatitis, and angular cheilitis. 
They also found out that use of antimicrobials, immunosuppressants, or drugs 
with xerostomic side effects was not related to the presence of Candida. Study 
concluded that the presence of Candida pseudohyphae was significantly 
associated with cigarette smoking, use of dentures, and poor glycemic 
control.
42
 
12. A study was conducted to explore the effect of periodontal therapy in 36 
persons with chronic renal failure who received therapy for adult periodontitis 
during an 18-month period. Another 36-person control group was randomly 
selected from the same population of persons with chronic renal failure and 
did not receive periodontal treatment. During the nine-month observation 
period, there was a improvement in the treatment group.
32
 
13. A study was conducted to assess the prevalence of chronic renal failure in 62 
OLP patients and also to investigate the existence of clinical and pathological 
differences between OLP patients with or without chronic renal failure. The 
variables studied for each patient were age, sex, clinical presentation, 
extension of the lesions, and location of the lesions, number of locations, 
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Candida albicans colonization, and density of subepithelial inflammatory 
infiltrate. Researchers concluded that OLP cases were associated to chronic 
renal failure. No significant differences could be observed in terms of clinical 
and pathological features between normal and chronic renal failure OLP 
patients.
56
 
14. A stomato-oncological study was carried out on 200 chronic renal failure 
patients and the control group included 280 adults. The lesions found were 
classified into inflammatory lesions, precancerous lesions and benign tumors. 
A retrospective chronic renal failure screening of 610 in patients with 
histologically confirmed oral malignancies was also performed. The control 
group comprised 574 complaint- and tumor-free adults. Researchers found 
benign tumors in 14.5% and precancerous lesions in 8% of chronic renal 
failure patients. In the control group these values were significantly lower. The 
proportion of oral cavity lesions was higher among chronic renal failure 
patients compared with that of the control patients. In the oral cancer patient 
group, was chronic renal failure present in 14.6% .These values are 
significantly higher than those for the tumor-free control group. The gingival 
and labial tumor location was significantly more frequent among chronic renal 
failure cancer patients than in the chronic renal failure group .The combination 
of chronic renal failure and smoking means a higher risk for oral precancerous 
lesions and malignancies. It was concluded that chronic renal failure may be a 
risk factor for oral premalignancies and tumors.
33
 
15. A study was conducted to investigate the effect of improved periodontal health 
on metabolic control in chronic renal failure patients. Fourty-four patients with 
chronic renal failure were selected. Subjects were randomly assigned into two 
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groups. The treatment group received full-mouth oral prophylaxis whereas the 
control group received no periodontal treatment. It was concluded that non-
surgical periodontal treatment is associated with improved health care and 
could be undertaken along with the standard measures for the chronic renal 
failure patient’s care.36 
16. A study was conducted to assess oral signs, symptoms and oral lesions its type 
and prevalence, in chronic renal failure patients. A total of 229 individuals 
were examined .They were divided into two groups ESRD on dialysis, and 
ESRD on non dialysis. Known evolution time, dialysis treatment type and 
duration, and laboratory results were recorded. An oral exam was performed, 
searching for signs, symptoms and ESRD-associated oral lesions. Signs and 
symptoms which are of higher prevalence in ESRD on dialysis are uremic 
breath, unpleasant taste and xerostomia  being the most frequent ones. The 
most frequent oral lesion was dry, fissured lips, saburral tongue and 
candidiasis. No difference was found in candidiasis prevalence between 
groups. Candidiasis was found associated to xerostomia  and smooth tongue 
only in group of patient on dialysis .Researchers concluded that  ESRD 
patients had a significantly higher prevalence of signs, symptoms and OLs, as 
compared to non dialysis patients.
58
  
17. A study consisting of 371 adult chronic renal failure subjects and 261 control 
subjects was carried out to assess the prevalence and predictor factors of 
burning mouth syndrome BMS. BMS or related discomforts occurred slightly 
more frequently in chronic renal failure patients than in the control group. 
Symptomatic chronic renal failure subjects were more likely to be female.
55
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18. A study was conducted to evaluate the prevalence of superficial lesions in the 
oral cavity mucosa in chronic renal failure patients. 30 chronic renal failure 
patients were selected .Thirteen different types of mucosal alterations were 
diagnosed. Tongue varicose veins and candidiasis were the most prevalent. 
Such alterations can be associated with the fact that these conditions are 
commonly found in senile patients and are also associated with prolonged 
wear of dentures. Xerostomia was diagnosed in only 3.33% patient, 
disagreeing with most of the studies observed in the literature. They have 
concluded that most of the chronic renal failure patients presented at least one 
type of oral mucosa lesion or alteration.
35
      
19. A study was done to compare chronic renal failure and normal subjects 
wearing complete dentures with regard to salivary flow, salivary buffering 
capacity, denture retention, and oral mucosal lesions in sixty subjects, 30 with 
and 30 without a diagnosis of renal failure, were matched for gender, race, and 
age. Salivary flow, salivary buffering capacity, glycemia, blood pressure, 
presence of mucosal lesions, denture retention, use of medications, and 
behavioural factors (controlled or uncontrolled diet, alcohol consumption, and 
smoking) reported by the subjects, were evaluated. It was concluded that no 
significant differences were observed in salivary flow, denture retention, or 
oral lesions in chronic renal failure and  normal subjects.
12
 
20. A study was done to investigate the oral manifestations in chronic renal failure 
and to establish an association between oral manifestations and associated 
microvascular and macrovascular complications. 50 cases of chronic renal 
failure were selected who had oral complications. The control group 
comprised 50 age- and sex-matched chronic renal failure patients without any 
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oral complications. It was found that oral manifestations in chronic renal 
failure included periodontal disease in 34%, oral candidiasis in 24%, tooth loss 
in 24%, oral mucosal ulcers in 22%, taste impairment in 20%, xerostomia and 
salivary gland hypofunction in 14%, dental caries in 24%, and burning mouth 
sensation in 10% cases. It was concluded that several oral complications are 
seen among chronic renal failure and association of oral markers in chronic 
renal failure and microvascular complications suggests that there is a 
significant association between the two.
25
 
21. A study was conducted to compare the clinical and subjective oral health 
indicators of chronic renal failure patients (154 chronic renal failure and 303 
healthy subjects) with age and gender matched controls as well as to identify 
clinical and subjective oral health indicators that discriminate between well 
controlled and poorly controlled chronic renal failure patients as well as 
between patients with long and short term duration. The results showed that 
chronic periodontitis,tooth mobility, furcation involvement and oral impacts on 
daily performance were more prevalent among chronic renal failure patients 
when compared to their controls.
46
 
22. A study was conducted in 51 chronic renal failure patients to determine the 
prevalence of oral mucosal lesions in patients with chronic renal failure. The  
result of the study shows a high prevalence of oral mucosal lesions in chronic 
renal failure  patients. lip and tongue were most common locations.
57
 
23. A study was carried out in 395 chronic renal failure patients and 405 healthy 
individuals to explore association between oral mucosal alterations and 
chronic renal failure. The result showed that the prevalence of oral mucosal 
lesions was higher in chronic renal failure and also provides evidence that 
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chronic renal failure has a negative influence on oral health. They also did not 
find any association between chronic renal failure and potentially malignant 
disorders.
48
 
24.  A study was conducted  by comparing 60 chronic renal failure patients with 
60 healthy subjects for evaluating various oral health complications associated 
with chronic renal failure. The results showed that altered taste, gingival 
enlargement, xerostomia, parotitis, enamel hypoplasia, delayed eruption, 
various mucosal lesions like hairy leukoplakia, lichenoid reactions, 
ulcerations, angular chelitis, candidiosis were the common manifestations. It 
was concluded that oral manifestations in chronic renal failure are more severe 
and intense monitoring of prevention as well as early treatment is necessary in 
both.
25
 
 
MANAGEMENT OF ORAL HEALTH COMPLICATIONS 
Hematologic Problems  
Recombinant human erythropoietin (epoetin alfa) (Epogen Amgen, Procrit 
Ortho Biothech Products; Aranesp, Amgen) corrects the anemia of ESRD and 
eliminates the need for transfusions in virtually all patients. A dosage of 50–150 U/kg 
of body weight IV three times a week produces an increase in hematocrit of 
approximately 0.01–0.02 per day. Therapy with recombinant erythropoietin is not 
without its potential dangers. “Normalization” of the hemoglobin or hematocrit is not 
recommended, as this has been shown to increase overall mortality in dialysis patients 
and rapid decline of renal function in non dialysis CKD patients. Recombinant 
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erythropoietin therapy in diabetic CKD patients doubles their likelihood in having a 
stroke. 
During early therapy, iron deficiency will develop in most patients. Therefore, 
it is initially essential to monitor the body’s iron stores monthly. With all patients, 
except those with transfusion-related iron overloads, prophylactic supplementation 
with ferrous sulfate (325 mg three times daily) or IV iron is recommended. 
14
Onset or 
exacerbation of hypertension has been observed as a possible complication of 
recombinant human erythropoietin therapy for the anemia of ESRD. This effect is 
attributed to an overly rapid increase in the hematocrit level in the accompanying 
increased hemoglobin, blood viscosity, and renal cell mass. 
Platelet defects secondary to uremia are best remedied by dialysis but are also 
treated successfully by cryoprecipitate or l-deamino-8-D-arginine vasopressin 
(DDAVP). Platelet numbers affect bleeding, and mechanical trauma to the platelets 
during dialysis can cause a decrease of up to 17% in the platelet count. In addition to 
lowered platelet counts (which are usually not clinically significant) and qualitative 
platelet defects, the effects of medications on platelets contribute to bleeding 
episodes. 
During dialysis, patients are given heparin to facilitate blood exchange and to 
maintain access patency. However, since the effects of heparinization during dialysis 
last only approximately three to four hours after infusion, the risk of excessive clinical 
bleeding because of anticoagulation is minimal in dentistry. Some patients have a 
tendency to be hypercoagulable; for these patients, a regimen of warfarin sodium 
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(Coumadin) therapy may be instituted to maintain a continuous anticoagulated state 
and to ensure shunt patency.
17
 
 Xerostomia   
Main objective in management of dryness of oral cavity is to encourage 
salivary stimulation to keep the mouth moist, prevent caries and candida infection.The 
use of saliva substitutes and stimulants is recommended. Patient can also be 
encouraged to chew sugarless gum to stimulate saliva production.
12
 
Candidiasis 
Topical and systemic agents are available for treatment of oral candidiasis. 
Clotrimazole troches are available and is given as 10mg troche 4 times/day for 2 
weeks. Systemic medications  commonly used are: Fluconazole 100mg/day for 2 
weeks Ketaconazole 200mg/day for 2 weeks Itraconazole 200mg/day for 2 weeks.
12
  
Gingivitis and Periodontitis 
The principle behind treatment of gingivitis is to reduce inflammation by 
eliminating plaque and calculus through scaling and polishing as untreated gingivitis 
progress to periodontitis. The use of a mouthwash is also recommended. Although 
there are many mouthwashes available, the efficacy of chlorhexidine has been shown 
to be very good. This drug has been shown to be the most effective antiplaque and 
antigingivitis chemotherapeutic agent available. 
Periodontal treatment is an essential requirement in a diabetic patient.
12
 The 
therapeutic goal in periodontal disease is to alter or eliminate the origin of the 
microbes and all contributing factors so as to prevent disease progression and to 
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prevent recurrent periodontitis .  Patients with diabetes should receive regular scaling 
so as to remove plaque and calculus deposits. Oral hygiene practices like brushing 2 
times/day and flossing should be reinforced by the dentist. 
The use of antibiotics is recommended and drugs  often  used are: Amoxicillin 
500mg three times a day for 5 days for patients who are not allergic to penicillin 
Erythromycin 500mg three times a day for 5 days for patients who are allergic to 
penicillin. Each of the above-mentioned drugs must be accompanied by any of the 
following: Metronidazole 400mg  three times a day for 5 days or Clindamycin 600mg 
three times a day for 5 days or Clavulanic acid and Amoxicillin 625mg two times a 
day for 5 days. These drugs target a broad spectrum of bacteria which is why they are 
used for periodontitis management.
16
 
Periodontal surgical procedures are performed on patients with advanced 
periodontitis. Surgical treatment of periodontitis involves removal of inflamed tissues 
to reduce the damage to the alveolar bone around the infected area and this has an 
added advantage since it enhances accessibility to areas where root planning and 
scaling could not be reached to remove plaque and calculus.
16
 
 Dental caries 
Dental caries is treated according to the severity of the lesion. If left untreated 
the caries will progress and eventually lead to tooth loss. It is important to remember 
the association of caries with hyposalivation since they may well be the contributing 
factor to dental caries in a diabetic. Caries is a process. In its early stages, tooth decay 
can be stopped. Topical treatments such as fluoride-containing mouth rinses and 
fluoride compounds, gels, aqueous solutions and dentrifices can prevent occurrence as 
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well treat initial caries.
30
 Dentists should also reinforce  oral hygiene practices and 
dietary counselling to the patient so that the patient can brush, floss and choose less 
cariogenic foods, all of which will enhance caries prevention.  
Once a lesion has cavitated, especially if dentin is involved, remineralization 
is much more difficult and a dental restoration is usually indicated operative 
treatment. Restorative materials include dental amalgam, composite resin, porcelain. 
In certain cases, endodontic therapy may be necessary for the restoration of a tooth. 
Endodontic therapy, also known as a root canal treatment, is recommended if the pulp 
in a tooth dies from infection by decay-causing bacteria or from trauma. During a root 
canal, the pulp of the tooth, including the nerve and vascular tissues, is removed along 
with decayed portions of the tooth. The canals are instrumented with endodontic files 
to clean and shape them, and they are then usually filled with a rubber-like material 
called gutta percha. The tooth is filled and a crown can be placed. An extraction can 
also serve as treatment for dental caries. The removal of the decayed tooth is 
performed if the tooth is too far destroyed from the decay process to effectively 
restore the tooth. 
Altered taste sensation 
This condition has a strong correlation for Candida and hyposalivation, a 
positive outcome is achieved by treating the accompanying fungal infection. 
Improvements in altered taste sensation may occur when metabolic control  is 
established or when hyposalivation and associated candidiasis are controlled. 
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DENTAL CONSIDERATIONS 
The dental considerations in  renal failure patients  include the following: 
Bleeding Tendencies 
If oral surgical procedures are necessary then careful hemostasis should be 
ensured . Dental treatment is best carried out on the day after dialysis when there has 
been maximal benefit from dialysis and the effect of the heparin has worn off. The 
hematologist should be first consulted. If  bleeding is prolonged, desmopressin may 
provide hemostasis for up to 4 hours. If this fails, cryoprecipitate may be effective, 
has a peak effect at 4 to 12 hours and lasts up to 36 hours. Conjugated estrogens may 
aid in hemostasis: The effect takes 2 to 5 days to develop, but persists for 30 days.21 
Infections 
They are poorly controlled by the patient with renal failure, especially if the 
patient is immunosuppressed, and may spread locally as well as giving rise to 
septicemia. Infections are difficult to recognize as signs of inflammation are masked. 
Hemodialysis predisposes to blood borne viral infection, such as hepatitis virus.
21 
Antimicrobials consideration include erythromycin, cloxacillin, fucidin and 
can be given in standard dosage. 
Lower doses of Penicillin, metronidazole and cephaloridine should be given, 
since very high serum levels can be toxic to the central nervous system. Benzyl 
penicillin has significant potassium content and may be neurotoxic and therefore 
contraindicated. Patients should be considered for antibiotic prophylaxis before 
extraction, scaling or periodontal surgery for those with polycystic kidney, those 
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receiving peritoneal dialysis, since bacteremia can result in peritonitis. Aspirin and 
other nonsteroidal anti-inflammatory analgesics should be avoided, since they 
aggravate gastrointestinal irritation and bleeding associated with renal failure. Their 
excretion may also be delayed leading to nephrotoxic, especially in the elderly or in 
renal damage or cardiac failure. Some patients have peptic ulceration, which is further 
contraindication to aspirin. Even COX-2 inhibitors may be nephrotoxic and are best 
avoided. Antihistamines or drugs with antimuscarinic side effects may cause dry 
mouth urinary retention. Fluorides can safely be given topically for caries 
prophylaxis. Systemic fluorides should not be given, because of doubt about fluoride 
excretion by damaged kidney. Antacids containing magnesium should not be given as 
there may be magnesium retention. Antacids containing calcium or aluminium bases 
may impair absorption of penicillin and sulphonamides.
22 
Hypertension 
Many renal patients are on antihypertensive therapy, digoxin and diuretics 
which may also complicate management. 
Local Anesthesia and Conscious Sedation 
Local anesthesia is safe unless there is severe bleeding tendency. Conscious 
sedation: Relative analgesia may be used. Midazolam is preferable to diazepam 
because of the lower risk of thrombophlebitis.
23
 
General Anesthesia 
Anemia which can be the contraindication to general anesthesia occurs in 
renal failure patients, if the hemoglobin is below 10gm/dl. Some of the difficulties 
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with general anesthesia are the patients with chronic renal failure which are highly 
sensitive to the myocardial depressant effects of anesthetic agents and may develop 
hypotension at moderate levels of anesthesia. Isoflurane and sevoflurane are safer. 
Induction with thiopentone followed by very light general anesthesia with nitrous 
oxide is generally the technique of choice. 
To reduce dry mouth, recommended use of alcohol-free mouthwashes or 
saliva substitute is advocated. 
All universal precautions should be followed as incidence of Hepatitis B and C 
are higher among dialysis patients. 
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SOURCE OF DATA  
This study was carried out in the Department of Oral Medicine and Radiology 
and Department of Nephrology, Sree Mookambika Institute of Medical Sciences, 
Kulasekaram, KanyaKumari district, Tamil Nadu 
METHOD OF SELECTION OF DATA 
1. Sample Size  
Total number of subjects: 50 
2. Selection of Cases 
Inclusion criteria:  
 Chronic renal failure patients undergoing hemodialysis clinically diagnosed 
with Oral Candidiasis, Uremic Stomatitis and Uremic frost.  
Exclusion criteria:   
 Patients not willing for study 
 Being Seropositive for HIV 
PARAMETERS TO BE STUDIED 
a) Acute pseudomembranous candidiasis 
b) Chronic erythematosus candidiasis  
c) Angular cheilitis 
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d) Uremic stomatitis 
e) Uremic frost 
       MATERIALS REQUIRED 
 Kidney Tray 
  Mouth mirror 
  Explorer 
  Mask 
 Gloves 
  Gauze 
  Beaker 
  KB006 HiCandida TM Identification Kit 
PROCEDURE IN DETAIL 
 50 patients diagnosed with chronic renal failure undergoing hemodialysis in 
the Department Of Nephrology, Sree Mookambika Institute of Medical Sciences will 
be included in the study after considering inclusion and exclusion criteria and 
obtaining the consent.  
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The study comprises of two stages: 
Stage 1: 
 A comprehensive history including the personal, family and past medical 
history will be recorded in a case history proform. The participants are requested to 
rinse the oral cavity with 10ml of distilled water for 30sec.The resulting liquid is 
collected in a beaker and then transferred into a conic tube .The sample is transferred 
to the Department of Microbiology and analyzed within 2hrs . A detailed intraoral 
examination is performed in all participants. Once a lesion is noticed (Clinically 
Uremic stomatitis is characterized by frank ulcerations with redness and pultaceous 
coat, while Uremic frost appears as white frost on the epithelial surface of oral cavity 
due to deposition of crystalline urea which is nonscrappable and Candidiasis appears 
as white plaque resembling as curdled milk which can be scrapped off.) patients are 
referred to the Department of Oral Medicine and Radiology for further treatment.  
Stage 2: 
 In the lab the liquid obtained by oral rinsing is centrifuged for 10mint at 3000 
rpm and the supernatant is discarded. Then 10µl of the sediment is plated on 
Sabouraud dextrose agar supplemented with chloramphenicol. Cultures are incubated 
at 37ºC for 2-3 days to assess the number of colony forming units by sub culturing in 
surface plating (using 0.001 ml of sample in a loop of 4mm). After that screening is 
performed by transferring the colony in KB006 HiCandida 
TM
 Identification Kit, 
where the organisms undergo a metabolic change which is indicated by spontaneous 
color change. All patient data are recorded in a case record form. 
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The present study was undertaken to find out the prevalence of candidiasis, 
uremic stomatitis, and uremic frost in chronic renal failure patients undergoing 
haemodialysis. 
The calculated minimal sample size was 44. A total of 50 patients agreed to 
participate in the study (26 male and 24 female). The mean age was 38 years (21–60 
years). While hemodialysis treatment  mean time was 32 months (1–180 months).  18 
patients (36%) presented lesions in the oral mucosa.  
The data was analyzed by Statistical Package for Social Sciences (SPSS 16.0). 
ANOVA (Post hoc) followed Dunnet t test and Chi square test was applied to find the 
statistical significance between the groups. P value less than 0.05 (p<0.05) considered 
statistically significant at 95% confidence interval. 
The analysis demonstrated significant association between colonization by 
yeasts and patient’s age (P = 0.04), chief complaint (P = 0.004), duration of the 
diseases (P = 0.03), duration of dialysis treatment (P = 0.03) and oral hygiene status 
(P = 0.03). However, no significant association was observed with gender.  
The percentage of patients affected by the disease was found to be higher 
between the age group of 40 -60 years of age and the analysis demonstrated that the 
results in relation to the presence of oral lesion and age changed and were no longer 
significant for the presence of yeasts. Common dental problems associated with these 
patients are periodontitis and dental caries.  Despite optimal dialysis, oral disease may 
be increased in these patients treated due to their   lower uptake of public dental 
services, as well as increased malnutrition and inflammation. 
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Nevertheless, chronic kidney disease patients undergoing hemodialysis 
treatment  were more likely to carry yeasts and its prevalence is higher when lesions 
were present in the oral cavity.  But our results demonstrated only 18 (36%) patients 
with CKD undergoing HT were colonized by yeasts, from which a total of 2 
subspecies were only isolated and identified, all belonging to the genus Candida with 
the predominance of C. albicans (22%). 
Clinical assessment detected more than one type of lesion in one of the 18 
patients with CKD undergoing HT with oral lesions. Candidiasis (acute 
pseudomembranous candidiasis, chronic atrophic candidiasis or angular cheilitis) was 
confirmed in 17 (34%) of the 18 lesions suggestive of the disease. Among the 
remaining lesion found, the diagnostic suggested uremic stomatits. Uremic frost was 
not seen in any patients.  
The only type of lesion to show positive association with the presence of 
yeasts was chronic erythematosus candidiasis, which is the kind of lesion typically 
resulting from the use of dental prosthesis. 
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Table-1: Distribution of patients based on age 
Age (Years) Number Percentage (%) 
Less than 20 years  2 4.00 
21-40 years  15* (p=0.04) 30.00*  
41-60 years  26* (p=0.04) 52.00*  
Above 60 years 7 14.00 
Total 50 100.00 
(*p<0.05 significant) 
 
 
Table-2: Distribution of patients based on gender 
Gender Number Percentage (%) 
Male 26 52.00 
Female 24 48.00 
Total 50 100.00 
(p>0.05 no significant) 
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Table-3: Distribution of patients based on oral examination 
Chief complaint Number Percentage (%) 
General oral examination 8 16.00 
Mobile tooth 4 8.00 
Bad taste  2 4.00 
Pain 10* (p=0.04) 20.00 
Sensitivity in upper posteriors 1 2.00 
Missing tooth 3 6.00 
Deposit in teeth  11* (p=0.04) 22.00 
Caries 7 14.00 
Root stumps 4 8.00 
Total 50 100.00 
(*p<0.05 significant) 
 
Table-4: Distribution of patient based on duration of ailment 
Duration of chronic 
renal diseases 
Number Percentage (%) 
2-5 years  32* (p=0.03) 64.00* 
6-10 years  8 16.00 
11-15 years  6 12.00 
16-20 years  3 6.00 
21-25 years 1 2.00 
Total 50 100.00 
(*p<0.05 significant) 
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Table-5: Distribution of patients based on duration of dialysis 
Duration of dialysis Number Percentage (%) 
Less than 1 year 18 36.00 
1-5 years  27 54.00 
6-10 years  4* (p=0.04) 8.00* 
11-15 years  1* (p=0.03) 2.00* 
Total 50 100.00 
(*p<0.05 significant) 
 
 
Table-6: Distribution of patients based on dental history 
Dental history Number Percentage (%) 
First dental visit  27* 
(p=0.04) 
36.00* 
Previous dental visit of restoration  12 54.00 
Previous dental visit of Extraction 11 8.00 
Total 50 100.00 
(*p<0.05 significant) 
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Table-7: Distribution of patients based on family history 
Family history Number Percentage (%) 
No relevant  family history 31 62.00 
Diabetes mellitus  10* (p=0.04) 20.00* 
Hypertension 9* (p=0.04) 18.00* 
Total 50 100.00 
(*p<0.05 significant) 
 
Table-8: Distribution of patients based on the status of oral hygiene 
Oral hygiene Number Percentage (%) 
No abnormality detected  2 4.00 
Mobility  4 8.00 
Dental caries  10 20.00 
Calculus 16* (p=0.03) 32.00* 
Generalized attrition  1 2.00 
Missing tooth 2 4.00 
Root stumps 7 14.00 
Ulcer on buccal mucosa 1 2.00 
Pain 7 14.00 
Total 50 100.00 
(*p<0.05 significant) 
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Table-9: Distribution of patients based on oral lesions 
Oral lesions Number Percentage (%) 
No abnormality detected 32* 
(p=0.02) 
64.00* 
Acute pseudomembranou s  candidiasis 3 6.00 
Chronic erythematous candidiasis 9 18.00 
Angular cheilitis 4 8.00 
Uremic stomatitis 1 2.00 
Chronic erythematous candidiasis, angular chelitis 1 2.00 
Total 50 100.00 
(*p<0.05 significant) 
 
Table-10: Distribution of patients based on Candida species 
Candida species Number Percentage (%) 
No Candida species   32* (p=0.04) 64.00* 
C. albicans 11 22.00 
C. tropicalis 7 14.00 
Total 50 100.00 
(*p<0.05 significant) 
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Table-11: Distribution of patients based on provisional diagnosis/final diagnosis  
Provisional diagnosis Number Percentage 
(%) 
Acute pseudomembranou s  candidiasis 1 2.00 
Chronic erythematous candidiasis 1 2.00 
Uremic stomatitis 1 2.00 
Root stump  7 14.00 
Chronic generalized periodontitis  13* (p=0.04) 26.00* 
Partially edentulous upper and lower arch 1 2.00 
Dental caries  12* (p=0.04) 24.00* 
Chronic generalized periodontitis ,Acute 
pseudomembranou s candidiasis 
2 4.00 
Acute pseudomembrane candidiasis ,Dental 
caries 
1 2.00 
Dental caries, chronic erythematous 
candidiasis 
3 6.00 
Chronic generalized periodontitis ,chronic 
erythematous   candidiasis 
1 2.00 
Chronic erythematous candidiasis, generalized 
attrition 
2 4.00 
Partially edentulous lower arch, chronic 
erythematous candidiasis 
1 2.00 
Chronic generalized periodontitis ,  angular 
chelitis 
2 4.00 
Dental caries, Angular chelitis 1 2.00 
Root stumps, Angular chelitis 1 2.00 
Total 50 100.00 
(*p<0.05 significant) 
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Graph-1: Distribution of patients based on age 
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Graph-3: Distribution of patients based on oral examination 
 
 
 
 
Graph-4: Distribution of patient based on duration of ailment 
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Graph-5: Distribution of patients based on duration of dialysis 
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Graph-8: Distribution of patients based on the status of oral hygiene 
 
Graph-9: Distribution of patients based on oral lesions 
0
10
20
30
40
50
60
70
No relevant  family
history
Diabetes mellitus Hypertension
P
er
ce
n
ta
g
e 
(%
) 
Family history 
0 10 20 30 40
No abnormality detected
Mobility
Dental caries
Calculus
Generalized attrition
Missing tooth
Root stumps
Ulcer on buccal mucosa
Pain
Percentage (%) 
O
ra
l 
h
y
g
ie
n
e 
Graphs 
   
 
 
 
Graph-10: Distribution of patients based on Candida species 
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Great physician Sir William Osler quoted “Mouth is the mirror to the body”. I 
would like to go one step further and state that the mouth mirrors what the body wants 
to show. 
Oral  physicians  can  play  a  pivotal  role  in  diagnosing  the undiagnosed 
cases of certain  disease on the basis of the oral signs and symptoms. The study of oral 
health abnormalities in chronic renal failure patient is important due to need of greater 
knowledge as well conflicting results in regards to the prevalence of oral 
abnormalities in literature as well as the fact that renal failure is a worldwide health 
problem. 
The present study was undertaken to determine the prevalence of candidiasis, 
uremic stomatitis and uremic frost and Candida subspecies in chronic renal failure 
patients. This study was conducted in the Department Of Nephrology and Department 
of Oral Medicine and Radiology, Sree Mookambika Institute of Medical Sciences, 
Kulasekaram, Kanyakumari district, Tamil Nadu. The total sample size was 50 
chronic renal failure patients undergoing hemodialysis in the Department Of 
Nephrology of Sree Mookambika Institute of Medical Sciences, Kulasekaram, 
KanyaKumari district, Tamil Nadu. Samples were selected based on our preformatted 
inclusion and exclusion criteria. 
This is one of the first studies to assess the presence of yeasts in the oral cavity 
and associate the results with the presence of oral lesions with the use of KB006 
HiCandida 
TM
 Identification Kit in patients with CKD undergoing HT. The results 
revealed that among the 50 patients studied, 18 (36%) were colonized by yeasts, all of 
them belonging to the genus Candida, with the predominance of C. albicans. 
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To avoid bias concerning treatment method and its possible complications, all 
patients in this study came from the same reference hospital. Although the number of 
participants was higher than the calculated minimum sample size, it was expected that 
a higher number of patients would be interested in participating in the study. The 
unwillingness demonstrated by patients to have the oral cavity examined may have 
been due to a series of reasons: the need to undergo hemodialysis three times a week, 
the considerable amount of time spent in hospital, their depressive state, the anxiety 
involved in waiting for organ transplant, or simply their general indisposed condition 
due to the constant alterations in their clinical status. None of the volunteers enrolled 
in this study had malignancy at the time samples were collected. Other confounding 
factors, such as the use of immunosuppressant, steroid, or history of previous oral 
candidiasis, were not taken into consideration, as all participants have been exposed to 
these variables at some point in their recent medical history. 
The rate of colonization by yeasts found in this study was almost similar to 
that found in a previous study performed with 146 patients receiving hemodialysis 
treatment (HT) by Godoy et al where there was 57 patients colonized with yeast with 
variability in species distribution
4
 lower than that found among 400 patients with head 
and neck cancer before treatment by Schelenz et al .The majority of infections in 
these cancer patients were caused by C . albicans and  almost one third  of patients  
harbored non C.albicans strains such as C.glabrata.
7
 The rate of colonization by yeasts 
found in this study was lower than that found in kidney transplant recipients by 
Ahmadieh et al
8
; and two times higher than that previously detected in healthy 
subjects by Yang et al 
40
. However, the incidence was lower than that found for HIV 
positive individuals by Junqueira et al 
29. 
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As a matter of fact, there is a great variability concerning the number of 
people that carry yeasts in the oral cavity. The high incidence rate found in this study 
in patients with CKD undergoing HT seems to indicate that some kind of interference 
in the host/Candida spp relationship may exist, which may favor the colonization by 
Candida spp. The importance of these results lies in the risk that these 
microorganisms might represent. Yeasts may become agents of serious and fatal 
infections, as seen in patients with cancer, in whom the prevalence of candidemia is 
high and the colonization rate is increased by the treatment itself. 
In this study, C. albicans represented 75% of all species isolated, which is in 
accordance with results found in previous studies. Even though no association 
between C. albicans and oral lesions (odds ratio) was found, our results reinforce what 
has been observed in daily dental practice, with C. albicans being the most commonly 
isolated species of yeasts found in the oral cavity, with incidences ranging from 
33.3% to 84.62%, of both healthy and ailing subjects. 
However, it is also important to call attention to the presence of non-albicans 
Candida species isolated both in the absence and in the presence of oral lesions, 
including those suggestive of candidiasis. Although the number of non albicans (C. 
tropicalis) species found in this study was small, their presence is still of great 
relevance from a clinical point of view. 
Some species of Candida such as C. tropicalis are not only highly virulent, but 
they also do not usually respond well to the treatment with antifungals.  As a result, 
the incidence of these fungal species in systemic infections involving high levels of 
morbidity and mortality has dramatically increased in the last decades. Thus, further 
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investigations associating non-albicans species and the presence of oral lesions could 
bring some relevant information on the impact these microorganisms may have on 
patients with CKD undergoing HT. 
Analyzing the possible variables associated with colonization rate (42.3%) by 
yeasts found in patients with CKD  undergoing HT, our results are in accordance with 
other groups of volunteers previously studied such as smokers,  patients with DM. 
The most common symptom  patients complained was burning sensation but some of 
them were asymptomatic too. Lamster et al
22 
indicated that the presence of candidiasis 
is a common manifestation of immuno compromised state.        
A study done in edentulous chronic renal failure patients by Bobkowska and 
Ziolkiewicz
46
  has shown that nearly 67 % had  denture stomatitis which is a form of 
candidiasis. Another study done by Bartholomew and Rodu
37
 in chronic renal failure 
patients  states  that there is predisposition to oral candidiasis and is independent of 
creatinine and blood urea nitrogen level. But the studies done by Knight and Fletcher 
38 
states that decreased  saliva output  promote overall growth of candida in these 
patients. The  results of  our study is consistent with this observation in the sense that 
the number of  patients  affected  by candidiasis is higher in edentulous chronic renal 
failure patients.  
In this study, a correlation between oral lesions and the presence of yeasts was 
clear. Patients with chronic erythematous were 15 times more likely to present yeasts 
in the oral cavity. Although expected, to the best of our knowledge, this is the first 
time that this finding has been estimated, which can be of relevance in handling 
fungal infections in patients with CKD undergoing HT. As they become more 
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common with age, removable dental prostheses can exert pressure on the subjacent 
mucosa, causing trauma and favoring the colonization by yeasts. Besides, the acrylic 
base can easily become a reservoir for microorganisms and be contaminated by 
yeasts, a scenario that may lead to oral infections, especially in immunosuppressed  
patients . The high chance of colonization by yeasts in patients with CKD receiving 
HT who are dental prostheses users found in this study suggests that the different 
members of the medical team responsible for these patients should be aware of this 
condition. This information indicates that continuous oral assessments, as well as 
reinforcement of oral and prostheses hygiene, should be performed, especially in the 
pre-transplant period. 
Angular chelitis (fissuring of the corners of mouth) was noticed in 20% of 
these population examined which also represents a form of candidiasis. This condition 
is of higher prevalence in renal failure patients as were in our study also. 
Guggenheimer et al 
42 
also reported a high prevalence of angular cheilitis associated 
with the presence of Candida.  
In this study the most important health complication noticed was Periodontitis. 
The prevalence of   periodontal disease was found to be 70%. It was found that long 
duration of disease can present  with severe manifestations of periodontitis like 
recession, furcation involvement ,mobility and pus exudation from periodontal 
pockets. The present study is consistent with study by Brian et al among 109 renal 
failure patients, the prevalence of periodontal disease was high , incidence of which 
being 2-6 fold higher.
23
 A study was done by Tsai et al
24 
in which it was proved that 
patients with chronic renal failure had a significantly higher prevalence of severe 
periodontitis. The level of creatinine and blood urea nitrogen  control is of key 
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importance in determining increased risk. Maike et al
25
 from his study suggested that 
incidence and severity of periodontitis are influenced by presence or absence of 
disease. Improving the creatinine  and blood urea nitrogen level  is likely to reduce 
risk and severity of periodontitis. Periodontal therapy  showed marked improvement 
in these patients . 
The relationship between dental caries and renal failure is complex.  literature  
states that patients with renal failure are susceptible to oral infection that leads to 
tooth decay and loss. Ship
32
 has stated in his review that he was not able to find any 
specific association of occurrence of dental caries in renal failure  patients which is 
quite contradictory to our study which shows that prevalence of decay and tooth loss 
is  high. Slight increase in prevalence of DMFT scores was observed in these patients. 
Halitosis was also noted in the study population though it was not a parameter 
in our study.  About 21% of the population examined had halitosis. It is primarily 
caused by bacterial putrefactions and generation of volatile sulphur compound. 
It is interesting to observe that the amount of yeasts isolated from patients with 
oral lesions (31.19 CFU/ml) was three times higher than that found in patients without 
oral lesions (9.50 CFU/ml) . These results are not surprising, as yeasts are either the 
agents responsible for the lesions themselves or opportunistic elements, taking 
advantage of tissue alterations to multiply and thus evolving from colonization to 
infection. Nonetheless, the number found was much lower than the 300 CFU/ml 
previously found in patients with lesions that were clinically suggestive of 
candidiasis. This difference may be due to the fact that results in this study reflect 
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mean CFU/ml detected in all patients, including all types of lesions, and not only in 
those clinically suggestive of fungal infection. 
Almost half of the population in this study (18) presented oral lesions, 
confirming its high prevalence in kidney patients. All these patients, supplied positive 
cultures for yeasts, presenting lesions clinically suggestive of oral candidiasis. Most 
yeast isolates were recovered from patients with chronic–atrophic– candidiasis-type 
lesions (nine lesions), from whom two species of yeasts were isolated. In addition to 
that, the yeasts isolated from these lesions were those recognized as being the main 
agents of lesions in the oral mucosa, that is, C. albicans and C. tropicalis , the first and 
the second most  common species, respectively. This correlation reinforces the 
recommendation made by Sahebjamee et al.
54
, who suggested that, due to the 
incidence and the high likelihood of serious infections, any type of oral lesion 
evidenced in kidney patients should be treated with antifungals before kidney 
transplant. Within this context, Ahmadieh et al. 
34
also suggested that when detecting 
an oral lesion, systemic investigation aiming at improving the prognosis would be 
opportune, with detection and treatment of the infection being initiated as early as 
possible.  
This study identified a high prevalence of oral mucosal lesions (candidal 
lesions) among patients with chronic renal failure. The lesions commonly noticed in 
Kanyakumari population were acute pseudomembranous candidiasis, denture 
stomatitis, median rhomboid glossitis, angular chelitis, geographic tongue, fissured 
tongue. Due to the high prevalence  of  these  lesions  in  the  population,  oral 
physicians  should be aware of the clinical appearance, etiology, diagnosis and the 
required treatment for the lesion. 
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The  prevalent mucosal lesion recorded was denture stomatitis (24.14%) But it 
was also observed  in our study that people in Kanyakumari district has higher 
incidence of geographic tongue  but  due  to  the  lack  of  similar studies in South 
Indian population, no conclusion can be drawn regarding the exact prevalence in this 
region. Most of the patients were asymptomatic .Very few patients were aware of the 
lesions. Males were more frequently to be affected than females in our study. Male 
predominance has been reported by Vörös-Balog et al.
39
   
However, a large discrepancy was observed  in this study  that uremic 
stomatitis and uremic frost were not seen  contradicting the expectations. Thus, it 
seems that clinical assessments of a lesion should be  confirmed by laboratory tests 
through the isolation and  identification of yeasts. Even then,   cultures positive for 
yeasts obtained from oral samples need to be interpreted with care, due to the 
possibility of a positive culture representing just an asymptomatic colonization 
without clinical implications.  
In this study, 64% of samples collected from patients were negative for yeasts, 
and curiously, 36% of lesions were suggestive of candidiasis (acute erythematous 
candidiasis, chronic atrophic candidiasis, or angular cheilitis).  Apart from the fact 
that the presence of yeasts may just indicate colonization, other diagnostic hypotheses 
must be considered for the presence of oral lesions, such as reactions induced by 
drugs, dietary habits, and malnutrition. 
The results of this study suggests, therefore, that close supervision concerning 
the use of dental prostheses and the occurrence of oral lesions, together with the 
performance of mycological tests, could ensure that patients comply with the pre-
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surgical requirements and are free of infection before transplant . Besides, in the face 
of the high occurrence of post-transplant oral candidiasis, these simple procedures 
could also enable the physician to individualize the antifungal prophylaxis, often 
empirically started . These conducts should all have in mind the high mortality rates 
and loss of the transplanted grafts owing to fungal infections, rendering early 
diagnosis and antifungal treatment mandatory in immunosuppressed patients. 
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Renal failure affects people of all ages and its prevalence is rapidly increasing. 
Systemic complications of renal failure were found to be significantly predominant 
among patients with oral health complications and increases the importance of the 
present study.  
The present study was undertaken to find out the prevalence of candidiasis, 
uremic stomatitis and uremic frost and Candida subspecies in chronic renal failure 
patient population. As Sir William Osler quoted “Mouth is the mirror to the body”   
the oral cavity can reveal signs of undiagnosed renal failure , hence oral health care 
providers must be well aware of signs and symptoms to refer them to a physician for 
further investigation as well as manage and treat the oral health complications.  
Significant observations were made and also it was noticed that C. albicans 
was the  most common subspecies in chronic rernal failure  patients. Due to the high 
incidence of yeasts found, and the likelihood of developing serious fungal infections, 
the results of this study indicate that when oral lesions are detected in patients 
undergoing HT, particularly in those who are prostheses users, early diagnosis and 
treatment of this type of lesion, in association with systemic investigations, should be 
performed to mitigate possible unfavorable prognosis.  
Knowledge of oral comorbidity among people with renal failure  is generally 
poor which could be clearly recognised from our study and also it requires oral health 
care providers to give appropriate health education to improve oral health status of 
renal failure  population. Hence patients should be encouraged to consult oral 
physicians on a regular basis to ensure the health of their oral cavity. The study also 
draws attention to promote oral health strategies at community level at large to help 
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people to understand the relationship that exhibits between renal failure  and oral 
health as their lack of awareness on  oral cavity problems among common people. 
The oral cavity exhibits the first sign of an undiagnosed renal failure , hence 
oral health care providers must be well aware of signs and symptoms to  refer them to 
a physician for further investigation as well as manage and treat the  oral health 
complications. Oral health providers can play an important role by identifying and 
treating oral diseases, by encouraging the renal failure  individual to maintain rigorous 
oral hygiene and follow proper diet. 
There is need for future longitudinal studies among renal failure  patients to 
elicit accurate knowledge regarding the development and progression of oral diseases 
as well as  results of interventional procedures and treatment (both medical and 
dental) instituted in the patients.  
We conclude our study by stating that oral physicians can play pivotal role to 
identify, treat various oral health problems, encourage patient to receive routine 
stomatological care thereby we can enhance the quality of life for patients with 
chronic renal failure.  
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CONSENT FORM  
PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
 
 
 
 
 
 
 
1.    Name of the Principal Investigator:  
 Divya N.L. 
 Second Year Post Graduate student  
 Department of Oral Medicine and Radiology 
 Sree Mookambika Institute of Dental Sciences, 
  Kulasekharam 
 
1. Name of the Guide : Dr. J. Eugenia Sherubin MDS. 
  Reader, 
  Department of oral medicine and Radiology, 
  Sree Mookambika Institute of Dental Sciences, 
  Kulasekharam, KanyaKumari District-629161.   
Dear Volunteers, 
We welcome you and thank you for your keen interest in participation in this research project. 
Before you participate in this study, it is important for you to understand why this research is being carried 
out. This form will provide you all the relevant details of this research. It will explain the nature, the 
purpose, the benefits, the risks, the discomforts, the precautions and the information about how this project 
will be carried out. It is important that you read and understand the contents of the form carefully. This 
form may contain certain scientific terms and hence, if you have have any doubts or if you want more 
information, you are free to ask the study personnel or the contact person mentioned below before you 
give your consent and also at any time during the entire course of the project. 
 
         
 
2. Name of the Co-Guide : Dr. Tatu Joy. E  MDS 
  Professor and Head, 
  Department of oral medicine and Radiology, 
      Sree Mookambika Institute of Dental Sciences, 
  Kulasekharam, KanyaKumari District-629161.  
 
3. Name of the Co-Guide : Dr. Beena Unnikrishnan MD,DM 
  Associate Professor  
  Department of Nephrology 
  Sree Mookambika Institute of Medical 
                                                              Sciences, 
  Kulasekharam, KanyaKumari District-629161.  
    
4. Name of the Co-Guide : Dr. R.V. Mookambika MD,DM 
  Assistant Professor  
  Department of Nephrology 
  Sree Mookambika Institute of Medical Sciences,                                                                                                                                                                      
  Kulasekharam, KanyaKumari District-629161   
5. Institute:   
   Sree Mookambika Institute of Dental Sciences, 
   V.P.M Hospital complex, Padanilam, 
Kulasekharam, 
   Kanyakumari – 629161 
   Tamil nadu 
2. Title of the study: “Prevalence of Candidasis, Uremic Stomatitis, Uremic 
frost and Colonization of Candidal subspecies in hemodialysis patients”   
 3. Background information: 
  Chronic kidney disease is a slow irreversible and progressive process that 
occurs over a period of years leading to death in the absence of medical 
intervention. Patients with chronic kidney disease, undergoing hemodialysis 
treatment are frequently colonized by yeasts of the genus Candida spp, with high 
chance of developing fungal infections. Oral candidiasis is an intermediary form 
between yeast colonization and invasive candidiasis .Although oral candidiasis is 
a superficial oral infection that is clinically detectable, it should be taken 
seriously due to its high potential to develop into a systemic infection in 
immune- compromised patients.             
 
4. Aims and Objectives:  
 
o To assess the presence of candidiasis, Uremic Stomatitis, Uremic 
frost in patients undergoing hemodialysis.   
o To assess the presence of various subspecies of Candida in patients 
with chronic renal disease undergoing hemodialysis in the 
Department Of Nephrology in  Sree Mookambika Institute of 
Medical Sciences. 
          
5. Scientific justification of the study:                       
 
    With impaired renal function, decrease GFR and accumulation and 
retention of various products of renal failure the oral cavity may shows a variety of 
changes as the body progresses through an azotemic to uremic state. In 90% of 
hemodialysis patient oral manifestation are evident which may be due to disease 
process or as a result of treatment. Studies have been conducted regarding 
colonization of yeast in hemodialysis patients. However there is a gap in the 
knowledge regarding assessment of Candida subspecies and its correlation with oral 
lesions in hemodialysis patient which aid in prophylactic treatment. Prevalence of 
Candidiasis, Uremic Stomatitis, Uremic frost and colonization of Candida 
Subspecies will open eyes in this new research.  
 
6. Procedure for the study:  
1. Obtain clinical records regarding data such as gender,history of systemic 
diseases,hemodialysis time of each patients. 
2. An informed consent was obtained from all participants. 
3. Patients were asked to rinse the oral cavity with 10ml of distilled water 
for 30sec. 
4. Then patient is asked to spilt into a beaker to obtain the sample. 
5. The samples are transported within 2 hrs to the laboratory for culture 
and identification of candida subspecies. 
6. A complete intra oral examination of the participants is carried out. 
7. Once a lesion and candida subspecies detected, patients are referred to 
the department of Oral Medicine And Radiology and treated with 
antifungal agents.     
7. Expected risks for the participants: 
                NIL 
8. Expected benefits of research for the participants: 
You will get a better knowledge about your oral health condition and 
various treatment and preventive options available to improve your oral 
health . 
9. Maintenance of confidentiality: 
a. You have the right to confidentiality regarding the privacy of your medical 
information 
(Personal details, results of physical examinations, investigations, and your 
medical     
   history). 
b. By signing this document, you will be allowing the research team 
investigators, other study Personnel, sponsors, institutional ethics committee 
and any person or agency required by law to view your data, if required.  
c. The results of study performed as part of this research may be included in 
your medical record.  
d. The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your identity. 
 
10. Why have I been chosen to be in this study? 
a. Chosen because of grouping under the inclusion and exclusion criteria  
b. Need of good sampling size 
c. No invasive procedure that harm your health and helps in diagnosis and 
helpful for the society 
11. How many people will be in the study? 50 
12. Agreement of compensation to the participants (In case of a 
study related injury):  
        No related injury anticipated. Patient will be taken care in case of complication 
and                  
  medical treatment will be provided. 
 
13. Anticipated prorated payment, if any, to the participant(s) of the 
study:     Not applicable. 
14. Can I withdraw from the study at any time during the study 
period? 
 The participation in this research is purely voluntary and you have the right 
to withdraw from this study at any time during the course of the study 
without giving any reasons.  
 However, it is advisable that you talk to the research team prior to stopping 
information. 
15. If there is any new findings/information, would I be informed?  
Yes 
16. Expected duration of the participant’s participation in the study: 
 1 day 
17. Any other pertinent information:   
No other information 
 
18. Whom do I contact for further information? 
 
 
 
 
 
 
 
 
 
Place:  
Date:         Signature of Principal Investigator
      
                                                   
                                                           Signature of the participant 
                                                   
 
 
 
For any study related queries, you are 
free to contact : 
  Dr.Divya N.L., 
  Post graduate student, 
  Department of oral Medicine and   Radiology 
  Sree Mookambika Institute of Dental  Sciences 
  Kulasekharam, 
  KanyaKumari District-629161 
  9841144518              
  divya_nl @ yahoo.com 
 
CONSENT FORM 
  PART 2 OF 2 
                 PARTICIPANTS CONSENT FORM 
The details of the study have been explained to me in writing and the details have 
been fully explained to me. I am aware that the results of the study may not be 
directly beneficial to me but will help in the advancement or medical sciences. I 
confirm that I have understood the study and had the opportunity to ask questions. I 
understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without the medical care that will 
normally be provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for scientific 
purpose(s). I have been given an information sheet giving details of the study. I fully 
consent to participate in the study titled 
“Prevalence of Candidasis, Uremic Stomatitis, Uremic frost and Colonization 
of Candidal subspecies in hemodialysis patients” 
Serial no / Reference no:   
       
Name of the participant: 
 
Address of the participant: 
 
Contact number of the participant: 
 
 Signature / thumb impression of the participant / Legal guardian Witnesses:  
   
1. 
 
2. 
Date: 
 
Place: 
Jl×Rp YôdÏêXm 
ØRp TôLm 
BWônf£«p TeÏùTßúYôÚdLô] RLYp Ï±l× 
 
BWônf£«u RûXl×: 
ÏÚ§d árUl TÏl× Øû\ ùNnÙm úSôVô°L°p HtTÓm úLu¥¥V£v, 
Ùìªd vùPUûPh¥v, Ùìªd ×ú\ôv égûN Eh£\l©]Øm LiP±Ùm BnÜ. 
 RûXûU BnYô[o : PôdPo. §qVô, Gu.Gp. 
 RÏ§ : ØÕLûX UôQYo, (Gm.¥.Gv) 
 ©¬Ü : J\p ùU¥£u & úW¥úVô[´ Õû\, 
 ¨ßY]m : c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
 CPm : ÏXúNLWm - 629 161 
 Y¯Lôh¥ : PôdPo. ë´]ô úNÚ©u MDS  
 RÏ§ : ÃPo 
 ©¬Ü : J\p ùU¥£u & úW¥úVô[´ Õû\, 
 ¨ßY]m : c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
 CPm : ÏXúNLWm - 629 161 
 CûQ Y¯Lôh¥ : PôdPo. PôhÓ ú_ôn. C MDS 
 RÏ§ : úTWô£¬Vo, Õû\ úUXô[o, 
 ©¬Ü :  J\p ùU¥£u & úW¥úVô[´ Õû\, 
 ¨ßY]m : c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
 CPm : ÏXúNLWm - 629 161 
 CûQ Y¯Lôh¥ : PôdPo. À]ô Eu² ¡ÚxQu 
   CûQ úTWô£¬Vo, 
   ¨lWôX´ Õû\, 
   c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
   ÏXúNLWm - 629 161 
 
 CûQ Y¯Lôh¥ : PôdPo. Bo.®. êLôm©Lô 
   ER® úTWô£¬Vo, 
   ¨lWôX´ Õû\, 
   c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
   ÏXúNLWm - 629 161 
 
ùLôsLs Utßm úSôdLeLs : 
 ÏÚ§ árUl TÏl×Øû\ ùNnÙm úSôVô°L°p HtTÓm égûN 
Eh£\l©]m LiP±Rp. 
 ÏÚ§d árUl TÏl×Øû\ ùNnÙm úSôVô°L°p HtTÓm úLu¥¥V£v, 
Ùìªd vùPUûPh¥v, Ùìªd ×ú\ôv LiP±Rp. 
Bn®u ùNVp Øû\ : 
 úSôVô°«u RLYpLs UÚjÕY BYQeL°u êXm GÓjÕ 
ùLôs[lTÓ¡\Õ. 
 CkR BWônf£«p Es[ úSôVô°L°Pm RLYpLû[ á± AàU§ GÝ§ 
YôeLlTÓm. 
 úSôVô°Ls 10 Gm.Gp Y¥¿Wôp YôûV 30 ®]ô¥ Su\ôL AXN úYiÓm. 
 AûR JÚ LiQô¥ ÏYû[«p úNL¬dL úYiÓm. 
 CkR TRdáû\ 2 U¦ úSWjÕdÏs BnÜdáPj§p Aàl© égûN 
LiP±V úYiÓm. 
 úSôVô°L°u Yô«u TÏ§ûV Su\ôL BnÜ ùNnV úYiÓm. 
 Yôn £ûRÜ Utßm égûN Eh£\l©]Øm LiP±kRôp JWp ùU¥£u 
Utßm úW¥VôX´ ©¬®p úSôVô°Lû[ ùLôiÓ ùNuß B]¥@TeLp 
UÚkûR ùLôÓjÕ ÏQlTÓjR úYiÓm. 
BWônf£«u G§oTôodLlTÓm TeÏLôX A[Ü?  JÚ Sôs 
TeúLtTô[oLÞdÏ G§oTôodLlTÓm TVuLs?  
 SpX JÚ UÚjÕYm úSôVô°LÞdÏ A°dLlTÓm. 
Bn®p LXkÕ ùLôsTYoLÞdÏ G§oTôodLlTÓm BTjÕdLs? 
 G§oùLôs[lTÓm BTjÕLs úSôVô°«Pm ùR¬VlTÓjÕm. 
CWL£VjRuûU LôjRp? 
EeL°Pm CÚkÕ úNL¬jR GkR ®TWØm CWL£VUôL ûYdLlTÓm. 
CRuêXm ¡ûPdÏm ×s°®TWm UhÓm ùY°«PlTÓm Ut\T¥ R²ST¬u ùNôkR 
®TWeLs ùY°«PlTPUôhPôÕ. 
CkR Bn®u êXm HúRàm ©u®û[ÜLs HtThPôp BWônf£Vô[o ùTôßl× 
HtTôWô?    BWônf£Vô[o ùTôÚ[ôRôW A[®p ùTôßlúTtTôo 
CkR BWônf£«p TeÏùTßúYôÚdÏ Gq®R ùRôûLÙm YZeLlTÓUô? CpûX  
CkR Bn®u êXm HúRàm ©u®û[ÜLs HtThPôp BWônf£Vôp TeÏ 
ùTßúYôÚdÏ Gq®R ùRôûLLs YZeLlTÓUô? ©u®û[ÜLs HtTPôÕ. 
Sôu CkR BWônf£«-ÚkÕ ®ÚlTlThPôp GkR LôXLhPj§Ûm ®XLXôUô? 
 úSôVô°«u GkR JÚ LhÓlTôÓ, ¨TkRû]L°u ¸r CkR Bn®tÏ 
EhTÓjRlTP®pûX. AYoL°u ØÝ JjÕûZl× Utßm NmURj§u úT¬p 
UhÓúU TeùLÓjÕs[]o. 
úYß HúRàm ùTôÚjRUô] ®TWeLs EiPô? CpûX 
CqYôWônf£ûVl Tt±V ®YWeLû[ Vô¬Pm úLhÓ ùR¬kÕd ùLôsYÕ? 
 RûXûU BnYô[o : PôdPo. §qVô, Gu.Gp 
 RÏ§ : ØÕLûX, (Gm.¥.Gv) 
 ©¬Ü : J\p ùU¥£u & úW¥úVô[´ Õû\ 
 ¨ßY]m : c êLôm©Lô Cuv¥hëh Bl ùPuPp NVu^v 
 CPm : ÏXúNLWm - 629 161 
 ûLúT£ : 9841144915 
 ªu AgNp : divya_nl@yahoo.com 
 
CPm :       ØRuûU BWônf£Vô[¬u 
úR§ :                   ûLùVôlTm 
 
 
 
 
 
 
 
 
 
 
 
 
 Jl×Rp T¥Ym 
TôLm : 2 
ÏÚ§d árUl TÏl×Øû\ ùNnÙm úSôVô°L°p HtTÓm úLu¥¥V£v, 
Ùìªd vùPUûPh¥v, Ùìªd ×ú\ôv égûN Eh£\l©]Øm LiP±Ùm BnÜ. 
TeÏ ùLôsTY¬u ùTVo   : 
18 YV§tÏ ¸r Es[YoLÞdÏ TôÕLôYX¬u ûLùVôlTm : 
ØLY¬ : 
 
ùRôûX ùRôPo× Gi : 
CkR BWônf£«u RLYpLs Aû]jÕm Gu²Pm ùR°YôL GÝjÕêXm 
®[dLlThÓs[Õ. CkR BWônf£«u Ø¥ÜLs G]dÏ úSW¥VôL 
TVuùT\ô®hPôÛm UÚjRYjÕû\«u Øuú]t\j§tÏ TVuTÓm GuTûR 
A±úYu. CqYôWônf£ûVl Tt± Sôu ùR°YôL ×¬kÕd ùLôiÓsú[u. Sôu 
Rô]ôL ØuYkÕ C§p TeÏl ùTß¡ú\u GuTûR A±úYu. C§-ÚkÕ GkR 
úSWØm GdLôWQØm á\ôUp YkRôÛm CkR UÚjÕYUû]«p G]dÏ ¡ûPdÏm 
UÚjÕY ER® Gq®Rj§Ûm Tô§dLlTPôÕ GuTûRÙm A±úYu. 
CqYôWônf£«u êXm YÚm Ø¥ÜLs Utßm RLYpLû[ A±®VpÕû\«u 
TVuTôÓLÞdÏ (UhÓúU) ETúVôLlThÓdùLôs[ NmU§d¡ú\u. G]dÏ 
CqYôWônf£ûVl Tt±V ®¬Yô] RLYpLs APe¡V T¥Ym RWlThÓs[Õ. 
TeÏ ùLôsTY¬u ùRôPo, UÚjÕY Gi  : 
TeÏ ùLôsTYo TWôU¬lTYo ûLùVôlTm / ùTÚ®Wp ÑYÓ :  Sôs : 
Nôh£ 1  
Nôh£Vô[¬u ûLùVôlTm Utßm ØLY¬     Sôs : 
Nôh£ 2 
úR§ : 
CPm : ÏXúNLWm 
RûXûU BnYô[¬u ûLùVôlTm 
 k½X ]{Xw þ `mKw þ 1  
]T\hpambn klIcn¡p¶ hyànIfpsS Adnhntebv¡v 
 
{]nbs¸« k¶² tkhItc, 
 R§Ä \n§sf kzmKXw sN¿p¶p.  AtXmsSm¸w Cu ]T\hpambn klIcn¡m\pÅ k¶²XtbmSv 
\µn tcJs¸Sp¯p¶p.  \n§Ä Cu ]T\¯nÂ ]s¦Sp¡p¶Xn\p ap³]v Cu ]T\w  F´n\mWv \S¯s¸Sp¶Xv 
F¶v Andtb­Xp­v. AXn\mÂ Cu t^md¯nÂ  KthjW ]T\¯nsâ hnhc§fpw aäpw  hniZambn 
tcJs¸Sp¯nbncn¡p¶p.  Cu ]T\¯nsâ coXn, Dt±iw, {]tbmP\w, A]ISkm²yX, t¢iw, ap³IcpXÂ, 
F§s\ Cu ]T\w  ap³t]m«p sIm­pt]mIp¶p F¶n§s\  FÃm hnhc§fpw  t^md¯nÂ  
tcJs¸Sp¯nbncn¡p¶p.  kZbw Cu  hnhc§Ä  hmbn¨p a\Ênem¡phm³  A`yÀ°n¡p¶p.  Cu hnhc§fnÂ 
imkv{X]camb ]Z§Ä DÅXn\mÂ  kwib\nhmcW¯n\p {][m\ ]T\IÀ¯mhnt\mtSm Xmsg tcJs¸Sp¯n 
bncn¡p¶ hyànItfmtSm t^mdw H¸nSp¶Xn\p ap³t]m AsÃ¦nÂ Cu ]T\¯nsâ Imemh[n Xocp¶Xphtctbm 
kao]n¡mhp¶XmWv.  
1. ]T\ hnjbw:  
 
càip²oIcW¯nteÀs¸« tcmKnIfpsS hmbnÂ Im³UnUnbmknkv bpdoanIv sÌma¡vssSänkv 
bpdqanIv t{^mÌv tI³UnUm k_vkv]ojkv I­dnbp¶ ]T\w.  
 
2. apJy KthjI³  :  tUm. Znhy. F³.FÂõ 
    c­mw hÀjw t]mÌp{KmPpthäv 
    Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn,    
    {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kv, 
    IpetiJcw þ 629 161. 
   
{][m\ amÀ¤ZÀin  : tUm.bqPn\nb sjdq_n³. 
s{]m^kÀ & slUv Hm^v Zn Un¸mÀ«psaâv, 
Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn 
{io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kkv, 
IpetiJcw. 
      
 
kl amÀ¤ ZÀin  : tUm. Smäp tPmbn 
doUÀ 
Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn 
{io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kkv, 
IpetiJcw. 
 kl amÀ¤ ZÀin  : tUm. _o\m D®nIrjvW³ 
AtkmÊntbäv s{]m^kÀ  
Un¸mÀ«vsaâv Hm^v  s\t{^mfPn Un¸mÀ«vsaâv 
{io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kkv, 
IpetiJcw. 
 
. kl amÀ¤ ZÀin  : tUm. BÀ.hn. aqImw_nI 
AknÌâv s{]m^kÀ  
Un¸mÀ«vsaâv Hm^v  s\t{^mfPn Un¸mÀ«vsaâv 
{io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kkv, 
IpetiJcw. 
 
 
3.  ]Tt\mt±iyw 
I\ymIpamcn PnÃbnse Z´mip]{XnbnÂ  sNÃp¶ càip²oIcW¯nteÀs¸« tcmKnIfnÂ  Im³UnUnb 
k_vkv]ojknsâ B[nIyw I­dnbmw. 
cà ip²oIcW¯nteÀs¸« tcmKnIfnÂ hmbv£X§fpsS càip²oIcW¯nteÀs¸« 
tcmKnIfpsS hmbnÂ Im³UnUnbmknkv bpdoanIv sÌma¡vssSänkv bpdqanIv t{^mÌv tI³UnUm 
k_vkv]ojkv I­dnbp¶ B[nIyw I­dnbmw.  
  
4.  ]T\coXn 
 
1.  tcmKnbpsS hyànhnhc§Ä Bip]{XntcJIfnÂ \ns¶Sp¡Ww. 
2.  NnInÕmcoXnIÄ tcmKn¡v hyàam¡pIbpw AhcpsS k½Xw  tcJs¸Sp¯pIbpw thWw 
3.  tcmKnIÄ 10 Fw.FÂ UnÌnÂUv shÅ¯nÂ hmb 30 sk¡âv IgpIWw 
4.  tcmKn AXv Hcp NjI¯nÂ  tiJcn¡pI. 
5.  tiJcn¨h 2 aWn¡qdn\pÅnÂ ]cntim[\ tI{µ¯nÂ Ab¡pI 
6.  tcmKnIfpsS hmb ]cntim[n¡pI 
7.  hmbv£Xtam Im³UnUnb k_vkv]ojnbknsâtbm km¶n²yw Dd¸ph¶mÂ tcmKnsb Un¸mÀ«psaâv       
Hm v^ HmdÂ saUnkn³ B³Uv tdUntbmfPnbnÂ Ab¨v Bâvdn^wKÂ GPâv sImSp¯v NnInÕn¡mw. 
]T\aqew ]s¦Sp¡p¶ BÄ¡v  D­mIm³ CSbpÅ A]IS km[yX    þ  A]IS km²yX CÃ 
5. Cu ]T\¯nsâ kab ssZÀLyw F{XbmWv ?    þ Hcp Znhkw 
6.  tcmKnIÄ¡v {]Xo£n¡p¶ KpW§Ä ? 
 tcmKn Bhiys¸SpIbmsW¦nÂ  Cu ]T\¯ns\mSphnÂ Gähpw \Ã NnInÕmcoXn \nÀt±in¡p¶XmWv. 
7.     ]T\^eambn tcmKn¡v Fs´¦nepw £Xw D­mIm³ km²yX Dt­m ?  CÃ 
8. hnhc§Ä clkyambn kq£n¡ptam ?        þ AsX 
9.     ]T\w aqeap­mIp¶ £X§Ä¡v \ã]cnloc¯n\pÅ k½Xw ? 
10. GsX¦nepw hn[¯nÂ thX\w e`n¡ptam?  þ CÃ 
11. ]T\w aqeap­mIp¶ £X§Ä¡v \ã]cnloc¯n\pÅ k½Xw ? 
 
 
12.      Ft¸mÄ thWsa¦nepw F\n¡v Cu ]T\¯nÂ \n¶v ]n·mdmtam ? 
 þ kz´w XmÂ]cy{]Imcw  ]T\¯nÂ \n¶v Ft¸mÄthWsa¦nepw ]n·mdmhp¶XmWv.  ImcW§Ä 
\ÂImsX Xs¶. F¶ncp¶mepw KthjW kwLt¯mSv ]n·mdp¶Xn\p ap³]v kwkmcn¡phm³ R§Ä 
\n§tfmSv A`yÀ°n¡p¶p.  
13. Cu KthjW¯nsâ ^eambn ]pXnb Fs´¦nepw Is­¯epIfps­¦nÂ AXv Fs¶ Andbn¡ptam 
         þ AsX 
14. IqSpXÂ hnhc§Ä¡mbn Xmsg ]dbp¶hsc \n§Ä¡v _Ôs¸Smhp¶XmWv.  
       tUm. Znhy. F³.FÂõ 
    c­mw hÀjw t]mÌp{KmPpthäv 
    Un¸mÀ«vsaâv Hm^v HmdÂ saUnkn³ & tdUntbmfPn,    
    {io aqImw_nI C³Ìnäyq«v Hm^v sUâÂ  kb³kv, 
    IpetiJcw þ 629 161. 
                samss_Â \¼À : 9841144915 
    CþsabnÂ sFUn: divya_nl@yahoo.com 
 
 
 
Øew:             {]Ya At\zjIsâ H¸v 
 
 
XobXn :         ]s¦Sp¡p¶ Bfnsâ H¸v 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
k½X]{Xw 
`mKw þ 2 
]T\¯nsâ Xes¡«v :  
                càip²oIcW¯nteÀs¸« tcmKnIfpsS hmbnÂ Im³UnUnbmknkv bpdoanIv sÌma¡vssSänkv 
bpdqanIv t{^mÌv tI³UnUm k_vkv]ojkv I­dnbp¶ ]T\w. 
]s¦Sp¡p¶ Bfnsâ t]cv: 
taÂhnemkw: 
 
 
 Cu ]T\s¯ ]änbpÅ FÃm Imcy§fpw F\n¡v ]dªv a\Ênem¡n XcnIbpw AXnsâ Hcp ]IÀ¸v 
F\n¡p \ÂIpIbpw sNbvXn«p­v.  Cu ]T\w KthjW¯n\mbn DÅXmsW¶pw F\n¡v  CXnÂ \n¶v  t\cn«v  
Hcp ^ehpw D­mInsÃ¶pw Rm³ a\Ênem¡p¶p.  Cu ]T\¯nsâ  coXnbpw Dt±ihpw F\n¡v  a\Ênem¡n 
X¶n«p­v.  AXp t]mse  F\n¡v kwib§Ä tNmZn¡m³  Ahkc§Ä  e`n¨n«pap­v.  CXnÂ ]s¦Sp¡m\pw  
]s¦Sp¡mXncn¡m\pw  DÅ AhImiw  F\n¡ps­¶pw  AXpt]mse  ]T\¯nsâ GXp L«¯nepw  CXnÂ 
\n¶v ]n³h§m\pÅ kzmX{´yhpw F\n¡ps­¶v  Rm³ a\Ênem¡p¶p. Cu ]T\¯nÂ ]s¦Sp¡p¶Xp 
sImt­m, ]s¦Sp¡m¯XpsImt­m Fsâ aäp NnInÕIsf _m[n¡p¶XsÃ¶v Rm³  Andbp¶p.  
 
]s¦Sp¡p¶ Bfnsâ  ssIs¿m v¸  :      XobXn: 
         
km£nbpsS ssIs¿m¸w :                                            XobXn: 
 
km£nbpsS t]cv aäpw taÂhnemkw:       XobXn: 
 
 
apJyAt\zjIsâ ssIs¿m¸v:       XobXn   
    
 
 
SREE MOOKAMBIKA INSTITUTE OF DENTAL SCIENCE 
DEPARTMENT OF ORAL MEDICINE AND RADIOLOGY 
 
Prevalence of Candidiasis Uremic stomatitis Uremic Frost and 
colonization of candidal subspecies in Hemodialysis patients  
                                                             
CASE SHEET PROFORMA FOR ASSESSING ORAL LESIONS IN 
HEMODIALYSIS PATIENTS 
 
OP NO 
NAME- 
AGE    - 
SEX    - 
OCCUPATION- 
ADDRESS- 
SOCIOECONOMIC STATUS- 
 
CHIEF COMPLAINT-      
          
          
    
 
 
MEDICATION/TREATMENT-     
          
          
     
 
 MEDICAL HISTORY-      
          
          
     
 
 DENTAL HISTORY   -      
          
          
    
 
 
FAMILY HISTORY: 
 
 
  
GENERAL EXAMINATION: 
Built Nourishment 
 
 
 
 
 
 
 
 
 
 
 
VITAL SIGNS: 
Pulse rate 
 
Respiratory rate 
 
Temperature 
 
BP 
 
 
 
  
Signs Yes No 
Pallor 
  
Jaundice 
  
Cyanosis 
  
Clubbing 
  
Pedal  oedema 
  
Regional lymphadenopathy 
  
LOCAL EXAMINATION 
 
                 a. Oral hygiene- Good/Fair/Poor 
 
 
 
 
 
 b. Candidiasis- 
1.  Acute pseudomembranous  candidiasis     
2. Chronic erythematosus candidiasis  
3. Angular cheilitis 
4. Uremic stomatitis 
5. Uremic frost 
 
c. Taste Alteration (dysgeusia)-  NCI  common terminology criteria 
for adverse events -  
Grade I-Altered taste but no change in diet  
Grade II-Altered taste with change in diet (e.g., oral supplements); noxious 
or unpleasant taste; loss of taste. 
Grade 1 Grade 2 
  
 
  
 
 
 
 
 
d. Other observations: 
PROVISIONAL DIAGNOSIS: 
 
 
 DIFFERENTIAL DIAGNOSIS: 
 
 
                 INVESTIGATIONS: 
 
 
               FINAL DIAGNOSIS: 
